0001171843-13-003427.txt : 20130816 0001171843-13-003427.hdr.sgml : 20130816 20130816140738 ACCESSION NUMBER: 0001171843-13-003427 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20130331 FILED AS OF DATE: 20130816 DATE AS OF CHANGE: 20130816 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Znomics, Inc. CENTRAL INDEX KEY: 0001371473 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-136372 FILM NUMBER: 131044795 BUSINESS ADDRESS: STREET 1: 2611 SW THIRD AVE., SUITE 200 CITY: PORTLAND STATE: OR ZIP: 97201 BUSINESS PHONE: 503-827-5271 MAIL ADDRESS: STREET 1: 2611 SW THIRD AVE., SUITE 200 CITY: PORTLAND STATE: OR ZIP: 97201 FORMER COMPANY: FORMER CONFORMED NAME: Pacific Syndicated Resources, Inc. DATE OF NAME CHANGE: 20060803 10-Q 1 f10q_073113.htm FORM 10-Q f10q_073113.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 10-Q

[X]
Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
     
 
For the quarterly period ended March 31, 2013
 
     
 
Or
 
     
[  ]
Transition Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934
 
     
 
For the transition period __________  to __________
 
     
 
Commission File Number:  333-136372
 

Znomics, Inc.
(Exact name of registrant as specified in its charter)

Nevada
52-2340974
(State or other jurisdiction of incorporation or organization)
(IRS Employer Identification No.)
 
301 Carlson Parkway, Suite 103
Minneapolis, MN  55305
(Address of principal executive offices, including zip code)
 
(952) 253-6032
(Registrant’s telephone number)
 
_______________________________________________________________
(Former name, former address and former fiscal year, if changed since last report)
 
Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the issuer was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days [   ] Yes    [X] No
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
[X] Yes    [  ] No
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
 
[  ] Large accelerated filer  [  ] Accelerated filer
[  ] Non-accelerated filer  (Do not check if a smaller reporting company) [X] Smaller reporting company
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   [X]   Yes [  ] No

State the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:  Common shares outstanding of 55,145,892 as of July 31, 2013.
 
1

 
TABLE OF CONTENTS
 
   
Page
 
PART I – FINANCIAL INFORMATION
 
 
PART II – OTHER INFORMATION
 
 
                                                                                                                                                                                           
 
2

 
PART I - FINANCIAL INFORMATION

FINANCIAL STATEMENTS
 
ZNOMICS, INC.
Balance Sheets (in thousands except share data)
(Unaudited)
 
Assets
 
March 31,
2013
   
December 31,
2012
 
Current assets:
           
Cash
 
$
20
   
$
26
 
Prepaid expenses
   
-
     
4
 
Total current assets
   
20
     
30
 
                 
                 
Total assets
 
$
20
   
$
30
 
                 
Liabilities and Stockholders' Deficit
               
Current liabilities:
               
Accounts payable
 
$
4
   
$
5
 
Accrued liabilities
   
41
     
41
 
                 
Total current liabilities
   
45
     
46
 
                 
Secured promissory notes from certain stockholders
   
150
     
150
 
Warrant liability      16        33  
                 
Total liabilities
   
211
     
229
 
                 
Stockholders' deficit:
               
Common stock, $0.001 par value, 90,000,000 shares authorized, 52,519,896 shares issued and outstanding at March 31, 2013 and December 31, 2012
   
53
     
53
 
Preferred stock, $0.001 par value, 10,000,000 shares authorized, none outstanding
   
-
     
-
 
Additional paid-in capital
   
6,403
     
6,403
 
                 
Accumulated deficit
   
(6,647
)
   
(6,655
)
                 
Total stockholders' deficit
   
(191)
     
(199)
 
                 
Total liabilities and stockholders' deficit
 
$
20
   
$
30
 
 
The accompanying notes are an integral part of these condensed financial statements.
 
3

 
ZNOMICS, INC.
Statements of Operations (in thousands except share data)
(Unaudited)
For the Three Months Ended March 31, 2013 and 2012
 
   
Three months ended
March 31
 
       
   
2013
   
2012
 
Revenue
 
$
-
   
$
-
 
                 
General and administrative expense
   
7
     
14
 
                 
Loss from operations
   
(7
)
   
(14
)
                 
Other income (expense):
               
Interest expense
   
(2
)
   
(1)
 
Gain on fair value adjustment of warrant liability
     17        -  
                 
Total other income (expense)
   
15
 
   
(1)
 
                 
Income (loss) before income taxes
   
8
 
   
(15
)
Income taxes
   
-
     
-
 
Net Income (loss)
 
$
8
 
 
$
(15
)
                 
Net income (loss) per share – Basic and diluted
 
$
0.00
 
 
$
(0.00
)
                 
Weighted average common shares outstanding:
               
Basic and diluted
   
52,519,896
     
52,519,896
 
 
The accompanying notes are an integral part of these condensed financial statements.
 
4

 
ZNOMICS, INC.
Statements of Cash Flows (in thousands)
(Unaudited)
For the Three Months Ended March 31, 2013 and 2012
 
  
 
Three Months Ended
March 31
 
   
2013
   
2012
 
Cash flows from operating activities:
           
Net income (loss)
 
$
8
 
 
$
(15
)
Adjustments to reconcile net loss to net cash from operations:
               
Stock-based compensation charges
   
-
     
1
 
Gain on fair value adjustment of warrant liability        (17 )       -  
Changes in operating assets and liabilities:
               
Prepaid expenses
   
4
     
(12)
 
Accounts payable
   
(1
   
19
 
Accrued liabilities
   
-
     
(8
)
                 
Net cash used by operating activities
   
(6
)
   
(15
)
                 
Cash flows from investing activities:
   
-
     
-
 
                 
                 
Cash flows from financing activities:
   
-
     
-
 
                 
Net decrease in cash and cash equivalents
   
(6)
     
(15)
 
                 
Cash at beginning of period
   
26
     
37
 
                 
Cash at end of period
 
$
20
   
$
22
 
                 
                 
                 
Supplemental disclosures:
               
Cash paid for interest
 
$
-
   
$
-
 
  
The accompanying notes are an integral part of these condensed financial statements.
 
5

 
ZNOMICS, INC.
Notes to Financial Statements

NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 
Nature of Business
 
Znomics, Inc. ("the Company") was engaged in the business of drug discovery with a cutting-edge biotechnology platform that leveraged medicinal chemistry with the unique attributes of the zebrafish.  In April 2009, the Company terminated its operations. The Company subsequently disposed of this developmental stage business in 2009 and 2010 prior to it having generated any significant revenues. As the Company is no longer developing any specific business, it no longer refers to itself as a development stage company and accordingly, no longer presents cumulative financial information. The Company is now considered a public shell company with no current business activity.
 
The Company has now focused its efforts on seeking a new business opportunity. The Company is attempting to locate and negotiate with a business entity for the merger of that target company into the Company. In certain instances, a target company may wish to become a subsidiary of the Company or may wish to contribute assets to the Company rather than merge. No assurances can be given that the Company will be successful in locating or negotiating with any target company. The Company will provide a method for a private company to become a reporting ("Public”) company whose securities are qualified for trading in the United States secondary market.
 
Basis of Presentation

The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“GAAP”).  However, certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed, or omitted, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”).  In the opinion of management, the financial statements include all adjustments consisting of normal, recurring adjustments necessary for the fair presentation of the results of the interim periods presented.  These condensed financial statements should be read in conjunction with the financial statements of the Company for the fiscal year ended December 31, 2012 as included in the Company’s 2012 Annual Report, dated August 14, 2013.
 
Estimates
 
The preparation of financial statements in conformity with GAAP requires us to make certain estimates, assumptions and judgments that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period.  We update these estimates, assumptions and judgments as appropriate, which in most cases is at least quarterly.  We use our technical accounting knowledge, cumulative business experience, judgment and other factors in the selection and application of our accounting policies.  While we believe the estimates, assumptions and judgments we use in preparing our financial statements are appropriate, they are subject to factors and uncertainties regarding their outcome and therefore, actual results may materially differ from these estimates.

Fair Value of Financial Instruments
 
The Company's financial instruments consist of cash, accounts payable, accrued expenses and notes payable. Fair value estimates are made at a specific point in time, based on relevant market information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. The Company considers the carrying values of its financial instruments in the financial statements to approximate fair value as interest rates on the notes payable approximate current rates and the current assets and liabilities are short-term in nature.
 
Derivative Financial Instruments

The Company has a derivative liability which is accounted for at fair value.  The fair value of the Company’s derivative liability is estimated at each balance sheet date and changes in fair value are reflected as a gain or loss in the statement of operations.  The Company utilizes a Black-Scholes option pricing model to estimate fair values of its derivative liability.

This derivative liability is also marked-to-market prior to any related exercises, modifications, or extinguishments with any necessary changes in fair value from the prior balance sheet date being reflected as a gain or loss in the statement of operations.  The carrying value of the liability is eliminated upon extinguishment, converted to equity upon an exercise, or adjusted as may be necessary in a modification.
 
 
6

 
ZNOMICS, INC.
Notes to Financial Statements
 
Income Taxes
 
Income taxes are provided for using the liability method of accounting. A deferred tax asset or liability is recorded for all temporary differences between financial and tax reporting.  Temporary differences are the differences between the reported amounts of assets and liabilities and their tax basis.  Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.  Deferred tax assets and liabilities are adjusted for the effect of changes in tax laws and rates on the date of enactment.
 
We account for income taxes pursuant to Financial Accounting Standards Board guidance.  This guidance prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return.  For those benefits to be recognized, a tax position must be more-likely-than not to be sustained upon examination by taxing authorities. We believe our income tax filing positions and deductions will be sustained upon examination and, accordingly, no reserves, or related accruals for interest and penalties have been recorded at March 31, 2013 and December 31, 2012.  In accordance with the guidance, the Company has adopted a policy under which, if required to be recognized in the future, interest related to the underpayment of income taxes will be classified as a component of interest expense and any related penalties will be classified in operating expenses in the statements of operations.  The Company has three open years of tax returns subject to examination from 2009 and forward.
 
Stock-Based Compensation
 
The Company recognizes the cost of stock-based compensation plans and awards in operations on a straight-line basis over the respective vesting period of the awards.  The Company measures and recognizes compensation expense for all stock-based payment awards made to employees and directors. The compensation expense for the Company's stock-based payments is based on estimated fair values at the time of the grant.
 
The Company estimates the fair value of stock-based payment awards on the date of grant using an option pricing model. These option pricing models involve a number of assumptions, including the expected lives of stock options, the volatility of the public market price for the Company's common stock and interest rates. The Company is using the Black-Scholes option pricing model to estimate the fair value of its options. Stock-based compensation expense recognized during the period is based on the value of the portion of stock-based payment awards that are ultimately expected to vest.
 
Net Income (Loss) Per Share
 
Basic net income (loss) per share is calculated by dividing the net income (loss) for the period by the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is calculated by dividing net income (loss) for the period by the weighted-average number of common shares outstanding during the period, increased by potentially dilutive common shares ("dilutive securities") that were outstanding during the period. Dilutive securities include options granted pursuant to the Company's stock option plan and stock warrants.
 
For the periods ended March 31, 2013 and 2012, outstanding options and warrants representing common stock equivalents were excluded from the calculation of the diluted net loss per share as their effect would have been anti-dilutive.
 
Comprehensive Income (Loss)
 
Comprehensive income (loss) includes net income (loss) and items defined as other comprehensive income (loss). Items defined as other comprehensive income (loss) include items such as foreign currency translation adjustments and unrealized gains and losses on certain marketable securities. For the three months ended March 31, 2013 and 2012, there were no adjustments to net income (loss) to arrive at comprehensive income (loss).
 
Recent Accounting Pronouncements

None that are applicable.
 
NOTE 2. GOING CONCERN
 
The Company's financial statements are prepared using generally accepted accounting principles applicable to a going concern that contemplates the realization of assets and liquidation of liabilities in the normal course of business.  We have incurred substantial losses since our inception. As of March 31, 2013, our accumulated deficit was approximately $6.7 million. Financial results for 2012 reflected a loss from operations of $109,000. We expect to continue to incur net losses as we incur expenses related to seeking a business opportunity and our ongoing costs of being a public reporting company.  Because we have no revenues, we plan to use our current cash reserves, which came from the cash received from advances under the Discretionary Notes (see Note 3), as well as potential future advances under the Discretionary Notes to fund our ongoing operating costs.
 
 
7

 
ZNOMICS, INC.
Notes to Financial Statements
 
Our ability to continue as a going concern is dependent on our success at finding an acquisition candidate in a timely manner.  We believe our cash position at March 31, 2013 and advances expected under the Discretionary Notes and equity sales of our common stock, should allow us to fund operations for at least the next 12 months, and through the date a target company merges into the Company.
 
However, the current financing environment in the United States is challenging and we can provide no assurances that we could raise capital either to continue our operations or to finance an acquisition. The sale of our securities or the expectation that we will sell additional securities may have an adverse effect on the trading price of our common stock. Further, notwithstanding the Discretionary Notes, we cannot be certain that additional financing will be available when and as needed. If financing is available, it may be on terms that adversely affect the interests of our existing stockholders. If adequate financing is not available, we may need to reduce or eliminate our efforts to find an acquisition opportunity. These factors could significantly limit our ability to continue as a going concern and cause us to investigate other strategic options, including bankruptcy.  The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

NOTE 3. DISCRETIONARY ADVANCE SECURED PROMISSORY NOTES
 
On February 10, 2010, the Company executed Discretionary Advance Secured Promissory Notes (the “Discretionary Notes”) in favor of various stockholders of the Company who may make advances to the Company from time to time.  The amounts due under the Discretionary Notes accrue interest at an annual rate of 5% and are due on the earlier to occur of a business combination between the Company and an operating business and three years from each loan advance, or upon the Company’s insolvency or a material breach of the Stock Purchase Agreement.  The Discretionary Notes are secured by all of the Company’s assets.  Advances totaling $150,000 have been received under the Discretionary Notes and remain outstanding at March 31, 2013.  Accrued interest of $7,600 is also due as of March 31, 2013.  See also Note 6, Subsequent Events.
 
NOTE 4.  Warrant Liability

During 2012, the Company re-reviewed the provisions on all of its outstanding warrants issued originally in 2009 and amended in 2010 and determined that because such warrants could potentially be settled in cash upon a Fundamental Transaction (as defined in the applicable warrant agreement), they should have been accounted for as a derivative liability at fair value with changes in fair value reflected in operating results.  Cumulatively since the date of issuance to December 31, 2012, the fair value of these warrants decreased by $68,000 to a December 31, 2012 fair value of $33,000.  The Company recorded a fourth quarter 2012 adjustment for all of its prior accounting treatment for these warrants.  No periods since issuance through December 31, 2012 were materially impacted by the previous accounting.

At issuance and each balance sheet date, the Company estimates the fair value of these warrants using the Black-Scholes option pricing model.  Changes in fair value are recorded as a non-cash valuation adjustment in the Company's statement of operations.  The Black-Scholes valuation model inputs for quarter ended March 31, 2013 are as follows:
 
 
 
Risk free interest rates 0.95%
Expected dividend yield 0.0%
Expected stock volatility 195.0%
Expected term of warrants in years 6.1
 
Expected volatility is based upon the observed historical trades of the Company’s common stock. The expected term of the warrants is based on the remaining terms of the warrants. The risk-free rate of return is based on the U.S. Treasury security rates for maturities consistent with the expected term of the warrants.

Potential future increases in the estimated fair value of these warrants will result in losses being recognized in our statement of operations in future periods.  Conversely, potential future declines in the estimated fair value of these warrants will result in gains being recognized in our statement of operations in future periods.  Neither of these potential gains or losses will have any impact on our cash balance, liquidity or cash flows from operations.
 
8

 
ZNOMICS, INC.
Notes to Financial Statements
 
The following table sets forth the changes in the Company's derivative warrant liability for the periods indicated:
Date
 
Description
 
Number of
Warrants
   
Warrants
Liability,
in thousands
 
                 
December 31, 2011
 
Balance of warrant liability at December 31, 2011
    -     $ -  
                     
   
Fair value of warrants reclassified to warrant liability during 2012
    1,686,510       101  
                     
   
Change in fair value of warrant liability for the year ended December 31, 2012
    -       (68 )
                     
December 31, 2012
 
Balance of warrant liability at December 31, 2012
    1,686,510       33  
                     
   
Change in fair value of warrant liability for the quarter ended March 31, 2013
    -       (17 )
                     
March 31, 2013
 
Balance of warrant liability at March 31, 2013
    1,686,510     $ 16  
 
NOTE 5.  Fair Value Measurements

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.  Entities are required to use a fair value hierarchy which maximizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value.  There are three levels of inputs that may be used to measure fair value:
                            
 
Level 1
-
Inputs use quoted prices in active markets for identical assets or liabilities.
 
 
Level 2
-
Inputs use other inputs that are observable, either directly or indirectly, other than Level 1 prices, such as quoted prices for similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 
Level 3
-
Inputs are unobservable inputs that are supported by little or no market activity and that are financial instruments whose values are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment or estimation.
 
If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.  The Company’s assessment of the significance of particular inputs to these fair value measurements requires judgment and considers factors specific to each asset or liability.

Level 3 Valuation Techniques

The warrant liability is classified as level 3 within the fair value hierarchy as its fair value is measured using the Black-Scholes option pricing model with several unobservable and estimated inputs, supported by little or no market activity.  The Black-Scholes valuation model inputs for the quarter ended March 31, 2013 are as follows:
 
 
Risk free interest rates 0.95%
Expected dividend yield 0.0%
Expected stock volatility 195.0%
Expected term of warrants in years 6.1
 
Expected volatility is based upon the observed historical trades of the Company’s common stock. The expected term of the warrants is based on the remaining terms of the warrants. The risk-free rate of return is based on the U.S. Treasury security rates for maturities consistent with the expected term of the warrants.

Significant increases (decreases) in any of those inputs in isolation could result in a significantly different fair value measurement. Generally a change in the assumption used for expected term is accompanied by a directionally similar change in the assumptions used for expected volatility and risk-free interest rate.
 
9

 
ZNOMICS, INC.
Notes to Financial Statements
 
The valuation methods described above may produce a fair value calculation that may not be indicative of the net realizable value or reflective of future fair values.  Furthermore, while the Company believes its valuation method is appropriate and consistent with similar instruments, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.

Liabilities measured at fair value on a recurring basis at March 31, 2013 are as follows, in thousands:

   
Quoted
Prices in
Active Markets
for Identical
Liabilities
(Level 1)
   
Significant
Other
Observable
Inputs
(Level 2)
   
Significant
Unobservable
Inputs
(Level 3)
   
Balance at
March 31,
2013
 
                         
Warrant liability
  $ -     $ -     $ 16     $ 16  
 
Liabilities measured at fair value on a recurring basis at December 31, 2012 are as follows, in thousands:

   
Quoted
Prices in
Active Markets
for Identical
Liabilities
(Level 1)
   
Significant
Other
Observable
Inputs
(Level 2)
   
Significant
Unobservable
Inputs
(Level 3)
   
Balance at
December 31,
2012
 
                         
Warrant liability
  $ -     $ -     $ 33     $ 33  
 
There were no warrants transfers between fair value levels during the quarter ended March 31, 2013.

The following table details the activity of our warrant liability measured at fair value, whose fair values are determined by Level 3 inputs, in thousands:

Balance, December 31, 2011
  $ -  
Fair value of warrants reclassified to liability
    101  
Gain on change in fair value of warrant liability recorded in other income (expenses)
    (68 )
Balance, December 31, 2012
    33  
Gain on change in fair value of warrant liability recorded in other income (expenses)
    (17 )
Balance, March 31, 2013
  $ 16  

The gain recorded in other income, for level 3 liabilities still held at March 31, 2013 and December 31, 2012 was $68,000 and $17,000, respectively.
 
NOTE 6. SUBSEQUENT EVENTS
 
On May 10, 2013, subsequent to quarter end, additional advances of $25,000 were received under the Discretionary Notes and remain outstanding.  In addition, on July 1, 2013, the stockholders who have made the above noted advances contributed $50,000 in exchange for 2,625,996 shares of Znomics common stock.
 
 
10

 
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
Forward-Looking Statements
 
Certain statements, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements generally are identified by the words "believes," "project," "expects," "anticipates," "estimates," "intends," "strategy," "plan," "may," "will continue," "will likely result," and similar expressions. Our forward-looking statements in this report generally relate to: (i) our intent to locate and negotiate with an operating company that would merge into the Company; (ii) our expectations with respect to the costs of completing a merger; (iii) our current intent not to compensate management; (iv) our expectations with respect to results of operations in the 2013 fiscal year; (v) our intentions with respect to our internal controls; and (vi) our beliefs with respect to our cash requirements, expenses, and the adequacy of cash. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements, including but not limited to our ability to identify operating companies that show an interest in merging with a public shell, unexpected delays in negotiating an agreement with a merger candidate, unexpected cash requirements, and other factors described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2012. Our ability to predict results or the actual effect of future plans or strategies is inherently uncertain.
  
Critical Accounting Policies and Estimates
 
In our Form 10-K filed with the Securities and Exchange Commission for the year ended December 31, 2012, we identified critical accounting policies and estimates for our business that we are incorporating herein by reference.
  
Plan of Operation
 
Management’s current intention for the Company is to:  (i) consider industries in which we may have an interest; (ii) seek and investigate potential businesses within the industries we select; and (iii) commence such operations through the acquisition of a "going concern" engaged in any industry selected.
 
During the next 12 months, our only foreseeable cash requirements will relate to maintaining our good standing as a public company and the payment of expenses associated with legal fees, accounting fees and reviewing or investigating any potential business venture.
 
On February 10, 2010, the Company executed Discretionary Advance Secured Promissory Notes in favor of each purchaser (the “Discretionary Notes”), who may make advances to the Company from time to time.  The amounts due under the Discretionary Notes will accrue interest at an annual rate of 5% and be due on the earlier to occur of a business combination between the Company and an operating business, or three years from each loan advance, or upon the Company’s insolvency or a material breach of the Stock Purchase Agreement executed on February 10, 2010.  The Discretionary Notes are secured by all of the Company’s assets.  Advances totaling $150,000 have been received under the Discretionary Notes and remain outstanding at March 31, 2013. On May 10, 2013, subsequent to quarter end, additional advances of $25,000 were received under the Discretionary Notes and remain outstanding.  In addition, on July 1, 2013, the stockholders who have made the above noted advances contributed $50,000 in exchange for 2,625,996 shares of Znomics common stock.

When and if an acquisition will be made is presently unknown and will depend upon various factors, including but not limited to funding and its availability and if and when any potential acquisition may become available to us at terms acceptable to us. The estimated costs associated with reviewing and verifying information about a potential business venture would be mainly for due diligence and the legal process.
 
 Results of Operations for the Three-Month Periods Ended March 31, 2013 and 2012
 
Revenue
 
The Company had no revenue during the three months ended March 31, 2013 and 2012.
 
11

 
Operating Expenses
 
General and Administrative Expenses.  Our operating expenses consist of general and administrative expenses.  General and administrative expenses currently consist principally of professional fees for legal, consulting, and accounting services, primarily related to our public company status and our due diligence efforts.   General and administrative expenses were $7,000 and $14,000 for the three months ended March 31, 2013 and 2012, respectively.

Financing Activities
 
We have incurred substantial losses since our inception. As of March 31, 2013, our accumulated deficit was approximately $6.7 million. Financial results for the first quarter of 2013 reflect a loss from operations of $7,000. We expect to continue to incur net losses as we incur expenses related to seeking a business opportunity and our ongoing costs of being a public reporting company.  Because we have no revenues, we plan to use our current cash reserves, which came from the cash received from advances under the Discretionary Notes, as well as potential future advances under the Discretionary Notes and sales of common stock to fund our ongoing operating costs.
 
Our ability to continue as a going concern is dependent on our success at finding an acquisition candidate in a timely manner.  We believe our cash position at March 31, 2013 and advances and equity contributions made subsequent to quarter end, will allow us to fund operations for at least the next 12 months, and through the date a target company merges into the Company.
 
However, the current financing environment in the United States is challenging and we can provide no assurances that we could raise capital either to continue our operations or to finance an acquisition.  The sale of our securities or the expectation that we will sell additional securities may have an adverse effect on the trading price of our common stock.  Further, notwithstanding the Discretionary Notes, we cannot be certain that additional financing will be available when and as needed.  If financing is available, it may be on terms that adversely affect the interests of our existing stockholders.  These factors could significantly limit our ability to continue as a going concern and cause us to investigate other strategic options, including bankruptcy.
 
Liquidity and Capital Resources
 
As of March 31, 2013, the Company had total current assets equal to $20,000, comprised exclusively of cash.  This compares with total current assets of $30,000, as of December 31, 2012, comprised of cash and prepaid expenses.  As of March 31, 2013, the Company had total current liabilities equal to $45,000, comprised of accounts payable and accrued liabilities.  This compares to $46,000 in total current liabilities, as of December 31, 2012, comprised of accounts payable and accrued liabilities.  The Company can provide no assurance that it can continue to satisfy its cash requirements for at least the next twelve months.
 
Cash Flows from Operating Activities
 
We used $6,000 of cash in operating activities for the three months ended March 31, 2013, a decrease of $9,000 compared to the three months ended March 31, 2012.  This reduction in cash used is primarily attributable to a reduction in our Net Loss for the period, a gain on fair value adjustment of warrant liability and changes in working capital items.
 
Cash Flows from Investing Activities
 
We had no investing activities for the three months ended March 31, 2013 and 2012.

Cash Flows from Financing Activities
 
We had no financing activities for the three months ended March 31, 2013 and 2012.
 
12

 
Liquidity

During the next 12 months, our only foreseeable cash requirements will relate to maintaining our good standing as a public company and/or the payment of expenses associated with legal fees, accounting fees and reviewing or investigating any potential business ventures, which may be advanced under the Discretionary Notes. The amounts due under the Discretionary Notes accrue interest at an annual rate of 5% and are due on the earlier to occur of a business combination between the Company and an operating business and three years from each loan advance, or upon the Company’s insolvency or a material breach of the Stock Purchase Agreement. The Discretionary Notes are secured by all of the Company’s assets. We believe the $25,000 of cash received on May 10, 2013 and the $50,000 received from the sale of common stock on July 1, 2013 and any potential future loans or equity contributions will be sufficient to meet our limited needs during the next twelve months. However, the stockholders are not obligated to make additional advances under the Discretionary Notes. If we require cash in addition to the amount currently on hand, there is no guarantee we will be able to obtain an adequate amount pursuant to the Discretionary Notes, and there is no guarantee we will be able to obtain alternative financing on favorable terms, if at all.
 
Off Balance Sheet Arrangements
 
As of March 31, 2013, we did not have any off balance sheet arrangements.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
 
As a smaller reporting company, we are not required to provide the information required by this Part I Item 3.
 
CONTROLS AND PROCEDURES
 
Evaluation of Disclosure Controls and Procedures
 
Under the supervision and with the participation of our management, including our chief executive officer and chief financial officer, we conducted an evaluation of the effectiveness, as of March 31, 2013, of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act. The purpose of this evaluation was to determine whether as of the evaluation date our disclosure controls and procedures were effective to provide reasonable assurance that the information we are required to disclose in our filings with the Securities and Exchange Commission, or SEC, under the Exchange Act (i) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure. In performing the assessment for the quarter ended March 31, 2013, our management concluded that our disclosure controls and procedures were not effective to accomplish the foregoing, due to the material weakness in internal control over financial reporting that was first identified in 2009 and was most recently described in Item 9A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2012.  Specifically, a lack of segregation of duties in the financial reporting process.
 
Changes in Internal Controls
 
During the fiscal quarter ended March 31, 2013, there was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
 
13

 
PART II – OTHER INFORMATION


LEGAL PROCEEDINGS
 
We are not a party to any pending legal proceeding. We are not aware of any pending legal proceeding to which any of our officers, directors, or any beneficial holders of 5% or more of our voting securities are adverse to us or have a material interest adverse to us.

RISK FACTORS
 
As a smaller reporting company, we are not required to provide the information required by this Part II Item 1A.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
 
None.
 
DEFAULTS UPON SENIOR SECURITIES
 
None.

MINE SAFETY DISCLOSURES
 
None.

OTHER INFORMATION
 
Pursuant to a letter agreement, dated March 27, 2013, the Company and Cherry Tree & Associates, LLC amended that certain engagement agreement dated February 10, 2010 (the "Cherry Tree Agreement") to extend the term of the Cherry Tree Agreement for an additional three years from February 10, 2013.
 
EXHIBITS
 
See "Exhibit Index" on page 13 of this Form 10-Q
 

 
14

 
 
In accordance with the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
Znomics, Inc.
 
 
Date: 
August 14, 2013
By: 
/s/ David G. Latzke
David G. Latzke
Title:
Chief Financial Officer
 
 
 
 
15

 
 
Exhibit Number
 
Description of Exhibit
10.1   Letter Agreement Amendment, dated March 27, 2013, by and between the Company and Cherry Tree & Associates, LLC
31.1
 
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)
31.2
 
Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)
32.1
 
Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith)
101*
 
The following materials from this report, formatted in XBRL (Extensible Business Reporting Language): (i) balance sheets, (ii) statements of operations, (iii) statements of cash flows, and (iv) the notes to the financial statements.
 
 
 
* Pursunat to Rule 406T of Regulation S-T, the XBRL-related information in Exhibit 101 to this Quarterly Report on Form 10-Q shall not be deemed to be "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, and shall not be deemed part of a registration statement, prospectus or other document filed under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such filings.
 
 
 
 
 
 
 
 
 

 16

EX-10.1 2 exh_101.htm EXHIBIT 10.1 exh_101.htm
Exhibit 10.1
 

March 27, 2013


Gordon F. Stofer
Chief Executive Officer
Znomics, Inc.


Dear Gordon,

This letter will serve to amend the Engagement Agreement between Znomics, Inc. (the “Company”) and Cherry Tree & Associates, LLC (“Cherry Tree”), dated February 10, 2010, pursuant to which Cherry Tree will act as the Company’s exclusive financial advisor in connection with a Transaction or Transactions involving the Company.

The term of the Engagement will be extended for a period of 3 years, from February 10, 2013.

All other terms of the February 10, 2010 Agreement remain in full force and effect.

If this letter correctly sets for the understanding between us, please so indicate by signing on the designated space below and returning a signed copy to us, whereupon this letter will constitute the Agreement between us.
 
 
Sincerely,



Cherry Tree & Associates, LLC

 
By /s/ David G. Latzke   Date:              
 
David G. Latzke, Managing Director
           
                     
                     
Znomics, Inc.
                 
                     
                     
By /s/ Gordon F. Stofer   Date:     By /s/ Kerry D. Rea   Date:  
 
Gordon F. Stofer, CEO
   
Kerry D. Rea, Director
                     
 
 
 
Cherry Tree & Associates, LLC
1 of 1
Confidential

EX-31.1 3 exh_311.htm EXHIBIT 31.1 exh_311.htm
Exhibit 31.1
 
CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
 
I, Gordon F. Stofer, certify that;
 
(1)
I have reviewed this quarterly report on Form 10-Q of Znomics, Inc.;
 
(2)
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
(3)
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
(4)
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
 
a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
 
b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
 
c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
 
d)
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
 
(5)
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of the internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
 
a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
 
b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
Date: August 14, 2013
 
 
/s/ Gordon F. Stofer
By: Gordon F. Stofer
Title: Chief Executive Officer
EX-31.2 4 exh_312.htm EXHIBIT 31.2 exh_312.htm
Exhibit 31.2
 
CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
 
I, David G. Latzke, certify that;
 
(1)
I have reviewed this quarterly report on Form 10-Q of Znomics, Inc.;
 
(2)
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
(3)
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
(4)
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
 
a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
 
b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
 
c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
 
d)
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
 
(5)
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of the internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):
 
 
a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
 
b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
Date: August 14, 2013
 
 
/s/ David G. Latzke
By: David G. Latzke
Title: Chief Financial Officer
EX-32.1 5 exh_321.htm EXHIBIT 32.1 exh_321.htm
Exhibit 32.1
 
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND
CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the accompanying Quarterly Report on Form 10-Q of Znomics, Inc. for the quarter ended March 31, 2013, I certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
(1)
 
the Quarterly Report on Form 10-Q of Znomics, Inc. for the quarter ended March 31, 2013 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
 
(2)
 
the information contained in the Quarterly Report on Form 10-Q for the quarter ended March 31, 2013, fairly presents in all material respects, the financial condition and results of operations of Znomics, Inc.
 

 
By:
/s/ Gordon F. Stofer
Name:
Gordon F. Stofer
Title:
Chief Executive Officer
Date:
August 14, 2013
   
   
   
   
By:
/s/ David G. Latzke
Name:
David G. Latzke
Title
Chief Financial Officer
Date:
August 14, 2013
GRAPHIC 6 header.jpg begin 644 header.jpg M_]C_X``02D9)1@`!`@$`8`!@``#_X08;17AI9@``34T`*@````@`!P$2``,` M```!``$```$:``4````!````8@$;``4````!````:@$H``,````!``(```$Q M``(````;````<@$R``(````4````C8=I``0````!````I````-````!@```` M`0```&`````!061O8F4@4&AO=&]S:&]P($-3(%=I;F1O=W,`,C`Q,SHP.#HQ M,R`Q-#HS,3HT,@```````Z`!``,````!__\``*`"``0````!```#(*`#``0` M```!`````1L`!0`` M``$```$F`2@``P````$``@```@$`!`````$```$N`@(`!`````$```3E```` M`````$@````!````2`````'_V/_@`!!*1DE&``$"`0!(`$@``/_M``Q!9&]B M95]#30`"_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)#!$+"@L1%0\, M#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P, M#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,#!$,#`P,#`P, M#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`%P"@`P$B``(1`0,1`?_=``0` M"O_$`3\```$%`0$!`0$!``````````,``0($!08'"`D*"P$``04!`0$!`0$` M`````````0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!``(1`P0A$C$% M05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D M1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F M]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#(3$2!$%187$B M$P4R@9$4H;%"(\%2T?`S)&+A7U5F9VAI:FML;6YO8G-T=7 M9W>'EZ>WQ__:``P#`0`"$0,1`#\`]525#.SV4O\`2<^S'8UILMR/2<6AK07[ M66ECZ-[MO^MEM2'5U?#H+*+Q;2'UMMKLN]^_U2]PJ#F.L=ZWM]E'_6\;U$DF M-`$]7325`=U]+ZW%G MN`=N(;59[/1=:[Z.5C[/W[+?2_G4D.@D@XV5CY5?JX[Q97,![>#H'2QWY['- M=[7L]B,DI22222E))))*4DDDDI222KNS\%MII=D5-M:0TUE[0X$Q#=A.[\Y) M3826-D96';F"ZI^+:+:PQCGY#F.=!]P%;&65[?TC/?\`RT&H465N>T465%CC M8X9MU@@:^I#F;7?S?O?]-)3OI+GV.H:!+L9Q+7D_K]Q81[J["6N8]K_S]^[\ M]1?9AFN/5Q"RPBP^IF6NU'M>YMCOY3OY"2GHDDDDE/\`_]#TR^A]E['V7!N/ M6014!&Y_%?J6%WN:UWT*MG\XLF_"Z2"!6_%-)93L-MSIU<[[+LVN]M7H^O\` M8O3_`,)_,KYT227>JAV\'Z.&)2#9#\7=N9N_2$S;ZUAQ_5W;MO\`E#UO3V_I MOMGJ?\(G.'B>M;Z[\5\NI)*]?B_47V1O^EM_SRE]D;_I;?\\KY=225Z_%^HOLC?\` M2V_YY2^R-_TMO^>5\NI)*]?B_47V1O\`I;?\\I_LK?\`2V_YY7RXDDKU^+]1 M_96_Z6SS]Y0;\;(EOV>P'G=ZKWS/YNWTS_77S$DDCU^+],G'ZCK#ZX(T!?9H M8^/]K_7>G^S]2CZ5.$))3009```` M```$````'CA"24T#\P``````"0```````````0`X0DE-!`H```````$``#A" M24TG$```````"@`!``````````(X0DE-`_4``````$@`+V9F``$`;&9F``8` M``````$`+V9F``$`H9F:``8```````$`,@````$`6@````8```````$`-0`` M``$`+0````8```````$X0DE-`_@``````'```/______________________ M______\#Z`````#_____________________________`^@`````________ M_____________________P/H`````/____________________________\# MZ```.$))300(```````0`````0```D````)``````#A"24T$'@``````!``` M```X0DE-!!H``````T4````&``````````````!S```#(`````@`90!X`&@` M7P`Q`#``,0`P`````0`````````````````````````!``````````````,@ M````7!E`````$YO;F4````) M=&]P3W5T)E\K.$P]-U MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$` M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D M8N%R@I)#4Q5C+RLX3#TW7C\T:4 MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B7I[?'_]H`#`,!``(1 M`Q$`/P#U5)4,[/92_P!)S[,=C6FRW(])Q:&M!?M9:6/HWNV_ZV6U(=75\.@L MHO%M(?6VVNR[W[_5+W"H.8ZQWK>WV4?];QO4228T`3U=-)4!USI;C`NF#'T' MQ,OK`G9^?93;57_I+*_3K3?MO$;D68][7TOK<6>X!VXAM5GL]%UKOHY6/L_? MLM]+^=20Z"2#C96/E5^KCO%ESV(R2E))))*4DDDDI2 M2222E))*N[/P6VFEV14VUI#367M#@3$-V$[OSDE-A)8V1E8=N8+JGXMHMK#& M.?D.8YT'W`5L997M_2,]_P#+0:A196Y[11946.-CAFW6"!KZD.9M=_-^]_TT ME.^DN?8ZAH$NQG$M>3^OW%A'NKL):YCVO_/W[OSU%]F&:X]7$++"+#ZF9:[4 M>U[FV._E._D)*>B22224_P#_T/3+Z'V7L?9<&X]9!%0$;G\5^I87>YK7?0JV M?SBR;\+I((%;\4TEE.PVW.G5SOLNS:[VU>CZ_P!B]/\`PG\ROG1))=ZJ';P? MHX8E(-D/Q=VYF[](3-OK6'']7=NV_P"4/6]/;^F^V>I_PB)ZUOKOQS>YP MG]*YK_5G%V;_`';VV?T#8YOZ3^@_\&OG!))7J\7Z;P<2C[,TTV167.+11837 MJXEVS^TC_9&_Z6W_`#ROEU))/K\7ZB^R-_TMO^>4OLC?]+;_`)Y7RZDDKU^+ M]1?9&_Z6W_/*7V1O^EM_SROEU))7K\7ZB^R-_P!+;_GE+[(W_2V_YY7RZDDK MU^+]1?9&_P"EM_SRG^RM_P!+;_GE?+B22O7XOU']E;_I;//WE!OQLB6_9[`> M=WJO?,_F[?3/]=?,222/7XOTR+]1?9&_Z6W_/*7V1O^EM_P`\KY=223Z_%__9`#A"24T$ M(0``````4P````$!````#P!!`&0`;P!B`&4`(`!0`&@`;P!T`&\`FMC.60G/SX*/'@Z>&UP;65T82!X;6QN#IX;7!T:STG6$U0('1O;VQK:70@,RXP+3(X+"!F&UL;G,Z6YT87@M;G,C)R!X;6QN&UL;G,Z97AI9CTG:'1T<#HO+VYS+F%D;V)E+F-O;2]E>&EF M+S$N,"\G/@H@(#QE>&EF.D-O;&]R4W!A8V4^-#(Y-#DV-S(Y-3PO97AI9CI# M;VQO&EF.E!I>&5L6$1I;65N&EF.E!I>&5L641I;65N&UL;G,Z<&AO=&]S:&]P M/2=H='1P.B\O;G,N861O8F4N8V]M+W!H;W1O3X*(#PO&%P.DUE=&%D871A1&%T93X* M("`\>&%P.D-R96%T;W)4;V]L/D%D;V)E(%!H;W1O&UL;G,Z>&%P34T])VAT='`Z+R]N M&%P+S$N,"]M;2\G/@H@(#QX87!-33I$;V-U;65N=$E$ M/F%D;V)E.F1O8VED.G!H;W1O&UL;G,Z M9&,])VAT='`Z+R]P=7)L+F]R9R]D8R]E;&5M96YT&UP;65T83X*("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`* M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"CP_>'!A8VME="!E;F0] M)W$S%F+P)'*"\25#-%.2HK)C<\(U1">3H[,V M%U1D=,/2X@@F@PD*&!F$E$5&I+16TU4H&O+C\\34Y/1E=865I;7%U>7U9G:& MEJ:VQM;F]C='5V=WAY>GM\?7Y_(B8J+C(V.CX*3E)66EYB9FINGM\?7Y_(B8J+C(V.CX.4E9:7F)F:FYR=GI M^2HZ2EIJ>HJ:JKK*VNKZ_]H`#`,!``(1`Q$`/P#W]BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5 M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5?_T/?V*NQ5 MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5 MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5 MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5 MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5 MV*NQ5__1]_8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7 M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7 M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7 M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7 M8J[%78J[%78J[%78J[%7_]+W]BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5= MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5= MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5= MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5= MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5?_T_?V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5U<5=BKL5=BK ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK__U/?V*NQ5 MV*NQ5V*H>^O+33K.:_OITM;*V1I;BXE8)''&@JS,S4``&$,HP,B`!9*$\OZ] MI7F?2+77M#NA>Z3?();2Z4,JR)4BH#A3U'<8EGEPSPS,)BI1YA,\#4[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[ M%78J[%78J[%78J[%78J[%78J[%78J[%6-^>7UB'R]<7.B3:C'>0$2"/1H;2Y MOI0`1PC2^_==2"2>PVQ5X_\`\K-\[WOEJZ\R6VKVR2>5?+VCZUJ-O!;*;?5+ MV]EG6ZB;U5]2-%%LT2K'Z;K.S3'_548H2SRQ<:_P"<-3U;S!<^8;G3M,TC6KS3 M+30[)+58?1TN8P.;QYH9)&:8J7^%XPD3)Q^+XRJD:_GD\GZ0@M=%2_OH)M(3 M3?J=V_U2\AUV\DL872XGM811)(SS9%DB*[QR/BJGI7YE:[I.IZC9ZS`D\-UY MHNM+_2%WNEN_Q2/,_U?U%B20JP:1&**54;/^=,UMIR^8+C M06'EJ_BUA]"NUNE:YN)-$@N+EEG@,8$*SQVTK1,'DX\1ZJHS4Q5DODOSOJ'F M34[_`$?6-(&D:A:6=AJD*QW0O$DLM4$HBY,(X^,BM`ZR)1E^R5=@<5>7^0/S M"\Z?HBR\T:G?76H:1<:;(^JRZ_"FG6`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`&2>>9MQ'%&@+.Q\`/GC=.;H M]#FU<^#$+(W/\V(_I%AB>8/S@\[QQW7E#2+3R=Y>G'*+4O,BOCI80L MJQ5[":7EXJ,%DNR_+Z'3;99'-/\`FXO3C_Y6RO\`V,5FM?DC<^<8K*+SYYVU MG7+:"XBN;G3$6UL=,N!$P;TY+:&(54TI\3LWO@,;9X>VAI^+P,,($BA/>>6/ MF)R/^]>K6=K!901VEK$L-M"BQPPQJ$1$04554;``;`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`XJRO%78J[%78J[%7 M8J[%78J[%78J_P#_UO?V*NQ51N;B&U@DN+B18H(5:265R`B(@Y,S$[``"I.* M0"30YEYIY4T9?/GF#_E:6OV?^BK']7\DV%RH8VU@3R:^9&V6>Z-&7;E'`L:_ M:+XC=W>JSG38ORN,[W>:4?XI?ZG?\W'_`+*3U`"F+HV\5=BK51BK>*NQ5V*N MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*L._-75-8T?R!K5[Y>N_J.NF.*VTZ]X+ M)Z-Q=SQV\;\7#*>+2`T(.*O.+3\S_,VN^8_*$-K-]3TR."XL/-]NB1EVUQ[& M^D]`,ZMQ-N]@ST'7UH^51MBJ.TS\Y]2BTBRNVT62^TNRTSRW?:WJEQ>1)=X M>X\N+E:7 MJ(N@;B6]TF.Z=O4M_2_=Q2FSF2-Q([CBIDC4/\*K&?,?YQZLWEKZ]?V$GEN1 M8_+/F*&:TG.H22:-JFJ0P31.J0J1*%#HT:"3FKCTW+8JGVJ_G3^B=&T/79], M@>VU:.*^EL8+Q[B^ATV[N4@@N.$%O)%TD5Y/4EBC#RW-OIB/$8/2]&:2T#.UP)_W(EC@1I(I(O4Y\>2 MJ`U+\Z-830&URPT&&.RU>PU>[\IW5Q=EC-+I$$EQ2[A2(&)98XGD3@\GV?3D M]-FQ5&G\W+_3&\JVNMZ?9R7FLKIB:K'I]U//+9R:Q+Z-O(4^JA!&S%?[V6)C M\0C63A\2J+\^ZWYDT'S3IM]<7=_IOY?JEG#=7VGP6%Q']?NKST>-V+@-.D-# M&O.!?A]0EBO'D%4+IVL^;4\Z:KH'F/4=2TVYU)=3E\JVRVVFRZ?)9VCHJ202 M('F,Z(Z.8[DJK<_LL%V58_H?G/SKK.H6GDJ;5;G3-2NM;U"TEOKRUM%UFUT^ MRT^.[ABFB1&M?5F:3FCHCJ;7_BWEQ5=IOGWSE?6GE3S5KMU>:;Y1NX+*TO[[ M2K:QFM)=6EU"6S8W*W'J7$<$O&$(T"T7UOB84Y!5[L.F^*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5__7]^DTQ5C?F/S_`.4?*,D4/F/58+"YG5I(+9R7GDCC^TZQ1AG* MCNW&F)H.7IM'GU%^%`R`VO\`AXN[BY//_,_G_P`F?F1Y3M?T'YDT]?)6HZ@- M/\T7MU=?HZ5;&)3)-#&LX0EI2$C;I^Y=V7(V".;N=/H-1H]01/'+Q(CBQB(X MQQ_PGTW]//\`K/2O+OF;ROYCMF?ROJEEJ=I:\8G;3YXITCV^%3Z9(78;9-TF MHT^;#*LL91E_2%(S6M8TWR_I%]KFLW*6>DZ=!)=7MU(:)'#"I9V/R`P.,\G_ M`"]\R^=_SKT]O.<-]-Y-_+R[DD3R[96D4+ZS?VT;%/K5S-<)*D".5/IQ11\^ M/Q-+BJWSQY>_-'R:VF>9O)7G'4M8TJVO[-/,?EO58;6],VFS7"1SR6TT4$E6JH:GQ#=5A_P"427FG?\Y2?FMH#:IJ.H:78:9IK64.I7L]\8?K'"9P MAG=B!R8T]ML4T^F<4.Q5V*NQ5V*NQ5V*O-/S%T_\Q]9\X>4--\D:Y-Y/U7=B4)'PJLC;],5><>:/,/YDZ)^??DG\JK;SS M?/H/F73+R_O;J2RTLW:2VJS%1&PM`H4F,5JC8JS_`$W1_P`S-"_-33/TCYGO M/,?D&^TN^1X)[2U@-IJ,4ENT;2O:0Q!@Z>H(^0^$ANO+%7J>*NQ5V*NQ5V*N MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*H M'5]'T[7K%M-U6`7-DTD,S0L64&2VE2>,U4@_"Z*WT8JE2^0_*<1O*KB!7TR*1+>[OM2B20NZ?6M569+MRK,0W MJK<2AE8ZM8Y-0OI'MI;,U@-M(\Y>$1]% M$3**?#TQ5?\`\JU\E_I&YU7]%J;NZ-R\BF6ZNG+2B^O&G,DGP\1TN)$5:<53:FV*H0?EAY$72H=#318 M(](M[2[TZ"TC:1$6TU"9)[B,<7!I))&K'O4;8JC?\$>6:AOT>E1J4NN`\I/^ M.E/&\+S_`&NI1V6GV=_LXJA9?RW\ES6<%A+I,36EKIR:);1EY?W>GQ21RI$I MYU!1XHW62OJ*R*ROBJZ;\OO+=U;V=I?+>7MM92^O'%=ZC?7"R2"1)5]<23MZ MP5XT95EYJI7X1BJG;?EIY*M+JYO(M*0R7<=U"\4DDTMO''J+6RF3379]/%G]7,EW=R`G3)#+:-('F(E:!B1$\G)D3X M!\&V*IOJODSR_K>J6^KZK!):@UO/+?7T4UM)GT7^5< M50[_`)8^37T]M.:RD*M=_I)KPW=U]?-X8O0,QO/5]?D8OW5?4_NOW?V-L55O M^5=>4?6TV06!$&D+;KIU@)[@6$)LO[AA:>IZ!>/JCF/D#1OM`8JRK%78J[%7 M8J[%78J[%78J[%78J__0]^D5Q4L>TSR7H&D:WJGF6VMS)Y@UA@U[J,[&6?TT M`"0QLW]W$M-HTHOE]_F7F6A_\XR?E[;^:M7\X>8K M&+5[[4;^>]L]/9>&G6LAS^TNKGIX8(2,(QB( MG^?+_._4EGGGR9I_Y+ZM_P`KD\A6JV.FPO%:^2>0`WHO3/R=^H_P#*I_(_Z.X_4_T%IOI<.G^\ ML=?QK7%!9M7%#Y,T'RK%YP_YRM_-_2;O4]0T[3FTS2#>1Z5<-937"^A"!&UQ M'25$ZU$3H6_:;CMBRZ*_Y=SW/Y._G_YS_+9-;U#4?RYB\M?XIM[35+F2]ELG MA9?4$0*SJ%5I9G1FDDYJW[L*N*I/^;4GYPZ1_SBI9:W^8&JZGH? MYBZ3<0Z?>BQOQ&+VUGNA$CW9M6(9VC(K1J\OB/7%0]F\H_DOJ5OK_P#CW6?/ M>O7NK:QH_P!1U"PAN!;Z?$\X1E>TC45B$(%(A\35^-W9B<5)>'?DW^7/FG\Y M_*_G;3]>_,/S!966D^:[R"QGM+IFO99[7TE$ES-)4NB(JB*)"B*Y>0U^'BJR MW_G(;0W_`"Z\X>0?S,74M6;R7)J\&F>=]/.I7@MI%G`$-TR)*JJ11C(%"QNR MI5?B.*@/0?-'E&U\]_G7I4,-[J%OI'E[2_TEYF6QU&[MH+R>\?TM.MI(X9E0 M!5BFF?B`S+Z8:JMBA[4!04&*OFG\P_\`ULK\J/\`MA:I_P`0N<4IO_SF&VJ: M=^2^L>8]&UO4]'O],:W51IMT]JDT=U<1PNLP2A8<6/'<4.*`Q_6="U'\H?*] MQ_SD7J_F[5M\$"VA!94A]'CQX_:;D M653R^_,7S)YI_,&T_+?S+I&K36OEWR]8ZCYTTGRS0RW.N:C&A$$LT587!<\2W$?K4/H#%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7 M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7 M8J[%78J[%7'IBKP6\_-#7M"@_1.JW4L^J>5=1UBZ\T3Q1PB>YT;3%$MF@4@( MK77UVQ3E\/\`NWXMCBK(-5_,K5[+4[30M?TYM%UBWU'1VN%TZ[CO+>6PU8W* MKRDEME;X6MI%EC5$?X5:.7BV*5>3\VM2@\MZ1YGN]"BM[/S3+;1^5X#=2S3/ M%=0RW0EO%@MI/2`@B]3C%]8;?AXMBJ._QOYMUKR3JFNZ!Y8FAU6+3)Y],ANF MKZVIP23PF!87$4K+^Z66-V6,3)(E.+@>4->\H^ M9KJ^OM8EL[:PT2[LK59-1*W%+][L)$'B]&$2&1HC%'"T?[?)5951_-KSUYK\ MMZZ;3R_/*EC8Z1^E+MK2VBNDMI#=>F)M4]52Z61C60UM_P!]^[F;]@8JHQ^= M_.'^.;#2+FZNH6UK6M0TJ'2?T:!8Q:3%9SSVFH6]ZT=)7(BCD<>JZ_O6B,2> MG7%4[\D>9?-MU%YVL+LW%_K6A.KZ+IVL0V]IJ3I+:P\I-J=XU[K::*+S4]0TM=/GTF\U"6Y%U!%%)$BN"MLR MV_J+*$DZR3C%+(X_.'G$Z9HLK:HOJV/G1_*VK3&UBY:E:)>M;*Y_9B;A_>>F MN\@/'@OPXH9)=:CYBM/S-TS2+'6GU*PO([FZUK16MH%@T[3UA(MYA-&@E$DE MP`BK([>JGJLJ+Z-<53CS!=W4/G;R=:PSO';7)U+ZS"K$))Z=L&3F.AXG<5Q5 MBOYJ:[KUAYL\HZ+I5UK,-AJ=MJ\]]#Y=AM)KV1[,6@B)^N(ZA%]5^5-ZE<57 M2?FO=V_F&Z\JV&F1ZO=0V=]+I\\=VZF:ZTA8C/;7,CVT<$4Q$G2.241NI67T M\53OR5^8-QY]TZR\PZ)HSGRKJ;7/U'4Y9XT?T;8*J/+`?C4RR^JBH.101\WX M\^.*O-M,\\_F??RRZ%:R7G6NGZ>:[^:_GWRQ+-+>F:<8;#3EL7`L;F&Y$:&>/BT9F/JRK)ZO\`NFG'%637VM>>K6/SGY>M M]4U35]4\LM97%C>Z59:V"7)W?84)2UV,CE$\;]#@-\PLY&+B"]LXJSQLA)XLB21T^&OPY%@GG MGWSSYR\U16GD[\M?+FM1-K,\-MJ_FV\LY=+M=,TV1P+F6+ZV(I9)O3Y+'Z:? M"QY5J`,58C^6VG^:;+_G)/S[YRO_`"GK%CY4\SV=C8:3J5S`@3G8QQHS2@2, MZ*W$\69?]:F*4'<>7_,.M?\`.3>M^9M0\I:RGD+6O++^4WU4P($]:5P'I_G5_SC_:R?E/K'Y>:GYW\L65S*?*_F+06A*_5IY"X M2;UF54')BWQLACY,OQ+Q;%62_P#.2>F_F-YZ_)4^58?*D]YYRU>ZMKMM.T@K MUZ!Y@=_*$&JW&C:G:3VMNJRZ3/ M;4O^<2*"JQJQ#5/0JU#BAXO_`,XKZ7YK\IP>;M%\V>5M5T2?6O,-]KEA<744 M9MVM;D)Q5I(I'XR#CNI^C%7J/YV>3['SW^5/FORS?LD4=UI\\L-Q)0+#<6R^ MO%(2>@5T!)_EKBJ2_P#..N@:UI?Y7:+JWFMS-YM\P6UMJ&JRN!S"BVC@M8C_ M`,8[>.)6_P"+.;?M8J]7)H*G%7RSYY/G?4?^/R9OO*OE+R[J>JZWKQM M9(+:*!4]!8+B.9OK!D=0AHM`N[5Q2$[\R^3IOSA_(B\\B75G=^7]4N].@M$C MU2'TI(;ZS6*2-F",P:/U$`+(3\/*F*&#_EG^9/Y\:#I%C^77FO\`*G4K_P`S MZ5$FGVWF*&XMX=%GB@4)'-/Q_E]YP M\Z^=&?4M8\G7/D_05BXP0:S+&=5GN"PW]"$LL42@'>1O4=C]A56K*L^Q5V*N MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*I!/Y(\IW.I:QJUSI M,$VH>8+./3=9EE!<7-G"'58G5B5XT=@:#XMN7V5HJ@K#\M?)>G*H@TTO(EW; M:@MQ<7%S.\O$2TFA9F1[,"8?52"[?[S^GLW'[.V*IM9^5M(L'DEMUN/7EM$TZ2XEN M[J:4V\32.OQR2,>8:5SZE?4_R_A6BJ`7\O/*D6E'1K:VGMK1[AKR>2VO;R"Z MFN'7@TDUS',LTK,OPGU)&^&G\JXJAG_*KR*U]8ZC%ILEI=Z9:1:;8M97M[9I M%9P/ZB0A+>:-"O+XF!7X_P!OEBK=]^5GD;4I6FO-,:1Y/7%Q2ZNE%Q'=3MD"L%'(0>GR(J=\50VG_E[Y4TQEEM;24W0NXM0:\FN[J>YDN;>)H8C+-+* MSR*B.RK&[-&O\M<56C\N?)PTR\TMM.,D.H3Q7EYDPDK'^QQQ5&0>2_+%MI6GZ+#IZKINEW2:A90\Y"5O(Y3,)F'6[^F*:`S&%J(.*@QT3 M]FF*HK5M"N-0\R>7M:BE1+?1S>&>)J\W^M0B)>--MCN:XJC[C1=,N]6L=>GZR@`T/+TDZC]G;%6-S_E3Y"N;J\NY])YRWPO!<+]9 MN1%QU-@UXJ1B4)&)V4-,$5?4/VNN*II9>2_+6F:D=6TZP%K>>M/=?N994A]: M[CCBF?T0_IU=8DK\'VAS^VS,55%/(7EF)=3].WF6ZU@HVH7XO+H7KB)R\:K< M^KZJ(C$E(T=42IXKN<52^Y_*;R'=V^G6\NFRH-*FN+JRE@OKVWG6YO=IYGEB MG2225P2&DD9GH2.6^*HB]_+7R??D27%G/]:1TECO$OKR.Z1X[=;3X)TF$BAH MD"2!6`E^U)R?XL51-OY#\J6UUI5U#IRJ=#B2#1K?U)6M;41JRJ\5N6,2R48C MU>'JT_;Q5#+^6GDX->2264TTU]$+>::>]O)I5@$RS^E#)),S11F158I$45J# MEL!BJ,/D?RM)=:K>W6GK>76MPO::E+>2271>UEJ7@43,XCA)-3%'P2N_'%4! M'^6/D^+3WTV&VNHH)9CK=Z;5Y8]F89:3'_?3_`+_)W#_4 M8_[Y[1YAT9]=TJ?3(M1O-)>?C2_TV18;N/BP;]V[JX%:4-5^SDGE\&48IB7" M)5_#+Z3[V#_\JCOO_+B^/_ M`"CX?]++_BG?\JCO_P#RXOG#_I/MO^R7&E_E>/\`RCX?]++_`(IW_*H[[K_R ML;SA_P!)]M_V2XTO\KQ_Y1\/^EE_Q3O^51WW_EQ?.'_2?;?]DN-+_*\?^4?# M_I9?\4[_`)5)?=/^5C><*_\`,?;?]DN-+_*\?^4?#_I9?\4[_E4E]_Y<;SA_ MTGVW_9+C2_RO'_E'P_Z67_%)9^9GE3\Q=8TWRE^7_EJ4WODZ_N4MO/VO7UPG MZ3.E0%'>,;('-R`TYDFO?EU<:WJLVH0> M/_*/A_TLO^*=_P`JCOO_`"XOG#_I/MO^R7&E M_E>/_*/A_P!++_BG?\JCOO\`RXOG#_I/MO\`LEQI?Y7C_P`H^'_2R_XIW_*H M[_\`\N+YP_Z3[;_LEQI?Y7C_`,H^'_2R_P"*=_RJ.^_\N+YP_P"D^V_[)<:7 M^5X_\H^'_2R_XIW_`"J.^_\`+B^/_`"CX?]++_BG?\JCO_P#RXOG#_I/MO^R7&E_E M>/\`RCX?]++_`(IW_*H[_P#\N+YP_P"D^V_[)<:7^5X_\H^'_2R_XIW_`"J. M_P#_`"XOG#_I/MO^R7&E_E>/_*/A_P!++_BG?\JCO_\`RXOG#_I/MO\`LEQI M?Y7C_P`H^'_2R_XIW_*H[_\`\N+YP_Z3[;_LEQI?Y7C_`,H^'_2R_P"*=_RJ M._\`_+B^/_*/A_TLO^*=_P`JCO\`_P`N+YP_Z3[;_LEQ MI?Y7C_RCX?\`2R_XIW_*H[__`,N+YP_Z3[;_`+)<:7^5X_\`*/A_TLO^*=_R MJ.__`/+B^/_`"CX?]++_BG?\JCO_P#RXOG#_I/MO^R7 M&E_E>/\`RCX?]++_`(IW_*H[_P#\N+YP_P"D^V_[)<:7^5X_\H^'_2R_XIW_ M`"J._P#_`"XOG#_I/MO^R7&E_E>/_*/A_P!++_BG?\JCO_\`RXOG#_I/MO\` MLEQI?Y7C_P`H^'_2R_XIW_*H[_\`\N+YP_Z3[;_LEQI?Y7C_`,H^'_2R_P"* M=_RJ._\`_+B^/_*/A_TLO^*=_P`JCO\`_P`N+YP_Z3[; M_LEQI?Y7C_RCX?\`2R_XIW_*H[__`,N+YP_Z3[;_`+)<:7^5X_\`*/A_TLO^ M*=_RJ.__`/+B^/_`"CX?]++_BG?\JCO_P#RXOG#_I/M MO^R7&E_E>/\`RCX?]++_`(IW_*H[_P#\N+YP_P"D^V_[)<:7^5X_\H^'_2R_ MXIW_`"J._P#_`"XOG#_I/MO^R7&E_E>/_*/A_P!++_BG?\JCO_\`RXOG#_I/ MMO\`LEQI?Y7C_P`H^'_2R_XIW_*H[_\`\N+YP_Z3[;_LEQI?Y7C_`,H^'_2R M_P"*=_RJ._\`_+B^/_*/A_TLO^*=_P`JCO\`_P`N+YP_ MZ3[;_LEQI?Y7C_RCX?\`2R_XIW_*H[__`,N+YP_Z3[;_`+)<:7^5X_\`*/A_ MTLO^*=_RJ.__`/+B^/_`"CX?]++_BG?\JCO_P#RXOG# M_I/MO^R7&E_E>/\`RCX?]++_`(IW_*H[_P#\N+YP_P"D^V_[)<:7^5X_\H^' M_2R_XIW_`"J._P#_`"XOG#_I/MO^R7&E_E>/_*/A_P!++_BG?\JCO_\`RXOG M#_I/MO\`LEQI?Y7C_P`H^'_2R_XIW_*H[_\`\N+YP_Z3[;_LEQI?Y7C_`,H^ M'_2R_P"*=_RJ._\`_+B^/_*/A_TLO^*=_P`JCO\`_P`N M+YP_Z3[;_LEQI?Y7C_RCX?\`2R_XIW_*H[__`,N+YP_Z3[;_`+)<:7^5X_\` M*/A_TLO^*=_RJ.__`/+B^/_`"CX?]++_BG?\JCO_P#R MXOG#_I/MO^R7&E_E>/\`RCX?]++_`(IW_*H[_P#\N+YP_P"D^V_[)<:7^5X_ M\H^'_2R_XIW_`"J._P#_`"XOG#_I/MO^R7&E_E>/_*/A_P!++_BG?\JCO_\` MRXOG#_I/MO\`LEQI?Y7C_P`H^'_2R_XIW_*H[_\`\N+YP_Z3[;_LEQI?Y7C_ M`,H^'_2R_P"*=_RJ._\`_+B^/_*/A_TLO^*=_P`JCO\` M_P`N+YP_Z3[;_LEQI?Y7C_RCX?\`2R_XIW_*I+[_`,N-YP_Z3[;_`+)<:7^5 MX_\`*/A_TLO^*=_RJ2^_\N-YP_Z3[;_LEQI?Y7C_`,H^'_2R_P"*=_RJ2^_\ MN-YP_P"D^V_[)<:7^5X_\H^'_2R_XIW_`"J2^_\`+C>/_ M`"CX?]++_BE7_E4E]_Y<;SA_TGVW_9+C2_RO'_E'P_Z67_%._P"527W_`)<; MSA_TGVW_`&2XTO\`*\?^4?#_`*67_%._Y5)??^7&\X?])]M_V2XTO\KQ_P"4 M?#_I9?\`%._Y5)>_^7&\X?\`2?;?]DN-+_*\?^4?#_I9?\4[_E4E]_Y<;SA_ MTGVW_9+C2_RO'_E'P_Z67_%._P"527O_`)<;SA_TGVW_`&2XTO\`*\?^4?#_ M`*67_%._Y5)??^7&\X?])]M_V2XTO\KQ_P"4?#_I9?\`%._Y5)??^7&\X?\` M2?;?]DN-+_*\?^4?#_I9?\4[_E4=]_Y<7SA_TGVW_9+C2_RO'_E'P_Z67_%. M_P"51W__`)<7SA_TGVW_`&2XTO\`*\?^4?#_`*67_%._Y5'?_P#EQ?.'_2?; M?]DN-+_*\?\`E'P_Z67_`!3O^51W_P#Y<7SA_P!)]M_V2XTO\KQ_Y1\/^EE_ MQ3O^51W_`/Y<7SA_TGVW_9+C2_RO'_E'P_Z67_%._P"51W__`)<7SA_TGVW_ M`&2XTO\`*\?^4?#_`*67_%._Y5'?_P#EQ?.'_2?;?]DN-+_*\?\`E'P_Z67_ M`!3O^51W_P#Y<7SA_P!)]M_V2XTO\KQ_Y1\/^EE_Q3O^51W_`/Y<7SA_TGVW M_9+C2_RO'_E'P_Z67_%._P"51W__`)<7SA_TGVW_`&2XTO\`*\?^4?#_`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`#QGL_JEM=:=I6E>7S:&\U>YLI+,M<:@I:"U576X9A&O M+U&6O!02<51L$<7EO\WDN];*:R_FB\FMM`U.&^D-UIKQ6)E>QFL>?I^@$AD= M9HQ\+O\`OD#,LK*O78;BWN0S6\J2JCM&YC8,%D0\64TZ$$4([8JP/\O=4BFU MSS]87-\)+F+S++';VLDO*1(1IMB_%$)J%J6:@%/M'%6':7YHU&+_`)QJL-5T MG5'DUR#1+)[V_B?ZU>6T,C1K2=#26X\H3"X M^O11//="_FU!IT%2DK/+-+R+5)]3]KQQ5EN*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*O*/S,UC\P M-/\`,-IH?D^=ED\S636^E2F!)8K+4=/E^L322,RD!9K9F0!S3FB\?B.*L7D\ MZ_F3JEAI^NZ3+<6MMYZFOM)T"TEM5)TJ=S`MG=2J8^5%2"\F?U/A;E&O\N*K M1Y[_`#*FT:W\XQ)<)#?:B_EN+0S:K^[O&LQ:I?O/%OH?F*2^Y7?FC2[270-"TYK9@NI>8-(MKBYN[E%C0$K,HC**&6-N!2/X MFQ5"2PGS7KOY?G0O.FH:H[3:N;SS`D-J+FUEDTU"T2H;41PU)!X21LZ;I\E4 MNTK\POS*U>Z\N175];:3>W.GZ-<6HO76QM]2N)Y72_#1&SF:1B%""**6%H69 M9/LL#BJ<:#JOG_5;_P`JI=^8+Z&VU[6O,$>H*EI;)Z%AHT]PEK"A:$\?4$2\ MY7JS\CPX_#15COF?7OS"U?RWYHTV\U>^T\^1)+:QUG4;")(9;VXDU2&=;@,L M;42/31'-*(PHY3L&^%*8JG6L>:O/5G%YEU;3]9N+K0[/6M-T>VF>."**WTBX MLK2XFU`SK:RDLSR%/5]-XH5=G]/X:JJE^H^=OS(BCTNS&O:?;Q7%E=7.C:\; MN/ZE>W:WLD<$-Q/^CV69HX1&)8X4MS+S:2-MO@59EJ_G;Z]YRT[3KCS#+Y?\ MJBVD"7UI$J+>ZY;7AM[BR::Z@D"B(*.**JM/ZA9'*QXJPN]_,+S['I^HWMEJ MES-YL2S\R2Z[Y::SC,.C#3K>X>PECI"'KZB0(OJ/(+P2ET%%^%5'SZU^8VC: MAJ8[_`%"#1+KRM+';S65J$ND\P7"V]]%(8X%/IQ*2\7IE6A/]X[KBKZ`& MPQ5V*NQ5V*NQ5V*NQ5V*NQ5V*O\`_]3W]BKL5=BKL5=BKL5=BJ33^4/*=U?7 M&IW.A:=-J5VOIW5Y):0//*FPXN[(68?"-B>PQ5-+BUMKN,0W4,<\09)!'*H= M0\3!T:C`BJL`RGL17%5.YT^PO'62[M89Y$22%'EC5V$$L:O]K?%4)>^5O+.IZC!J^I:+87FK6W#ZM?W%K#+<1>D MQ=.$CJ67BQY+0['%5T/EOR]:ZK/KUKI-E!KMR.-QJD=O$EW(IH*/,%#L/A'4 M]L5=H'E_2_+.G#2]'A]"S]:XN6!9G9I[R9[B9V9B26>21F).*M+Y7\M)K!\P MIHUBNOM7EJHMH1>&J\#68+S^S\/VOL[8JUI/E;RSH,D\NA:+8:7+=4%R]E:P MVS2@$DD>6?+>@27$NA:/8Z7+=D&Z>RMHK9I2I)',QJO*A)Z^ M.*IKBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BK5`<5=08JW3%6J#%74&*NH,5=08JEFA>7M)\MV;V M.D0&&*6>6[G=W>:66XN&+R2R22%G=F/=B=J+]E0,532@Q5U!BK5!X8JZ@Q5U M!X8JWBKL5=BKL5=BKL5=BKL5=BKL5?_5]_8J[%78J[%78J[%78J[%78J[%78 MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78 MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78 MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78 CJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7_]D_ ` end EX-101.INS 7 znom-20130331.xml XBRL INSTANCE DOCUMENT 0001371473 2013-03-31 0001371473 2012-12-31 0001371473 2013-01-01 2013-03-31 0001371473 2012-01-01 2012-03-31 0001371473 2011-12-31 0001371473 2012-03-31 0001371473 2013-07-31 0001371473 2012-01-01 2012-12-31 0001371473 2013-10-01 2013-12-31 0001371473 us-gaap:FairValueInputsLevel3Member 2013-03-31 0001371473 us-gaap:FairValueInputsLevel3Member 2012-12-31 0001371473 us-gaap:SubsequentEventMember 2013-01-01 2013-05-10 0001371473 us-gaap:SubsequentEventMember 2013-07-01 2013-07-31 iso4217:USD iso4217:USD xbrli:shares xbrli:shares xbrli:pure 20000 26000 4000 20000 30000 20000 30000 4000 5000 41000 41000 45000 46000 150000 16000 33000 211000 229000 53000 53000 0 0 6403000 6403000 6647000 6655000 -191000 -199000 20000 30000 0.001 0.001 90000000 90000000 52519896 52519896 52519896 52519896 0.001 0.001 10000000 10000000 0 0 7000 14000 -7000 -14000 2000 1000 17000 15000 -1000 8000 -15000 0 0 8000 -15000 0.00 0.00 52519896 52519896 8000 -15000 1000 -4000 12000 -1000 19000 -8000 -6000 -15000 -6000 -15000 37000 22000 Znomics, Inc. 10-Q --12-31 55145892 false 0001371473 Yes No Smaller Reporting Company No 2013 Q1 2013-03-31 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font></font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Nature of Business</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Znomics, Inc. ("the Company") was engaged in the business of drug discovery with a cutting-edge biotechnology platform that leveraged medicinal chemistry with the unique attributes of the zebrafish.&#160;&#160;In April 2009, the Company terminated its operations. The Company subsequently disposed of this developmental stage business in 2009 and 2010 prior to it having generated any significant revenues. As the Company is no longer developing any specific business, it no longer refers to itself as a development stage company and accordingly, no longer presents cumulative financial information. The Company is now considered a public shell company with no current business activity.</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company has now focused its efforts on seeking a new business opportunity. The Company is attempting to locate and negotiate with a business entity for the merger of that target company into the Company. In certain instances, a target company may wish to become a subsidiary of the Company or may wish to contribute assets to the Company rather than merge. No assurances can be given that the Company will be successful in locating or negotiating with any target company. The Company will provide a method for a private company to become a reporting ("Public&#8221;) company whose securities are qualified for trading in the United States secondary market.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Basis of Presentation</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;).&#160;&#160;However, certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed, or omitted, pursuant to the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;).&#160;&#160;In the opinion of management, the financial statements include all adjustments consisting of normal, recurring adjustments necessary for the fair presentation of the results of the interim periods presented.&#160;&#160;These condensed financial statements should be read in conjunction with the financial statements of the Company for the fiscal year ended December 31, 2012 as included in the Company&#8217;s 2012 Annual Report, dated August 14, 2013.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Estimates</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The preparation of financial statements in conformity with GAAP requires us to make certain estimates, assumptions and judgments that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period.&#160;&#160;We update these estimates, assumptions and judgments as appropriate, which in most cases is at least quarterly.&#160;&#160;We use our technical accounting knowledge, cumulative business experience, judgment and other factors in the selection and application of our accounting policies.&#160;&#160;While we believe the estimates, assumptions and judgments we use in preparing our financial statements are appropriate, they are subject to factors and uncertainties regarding their outcome and therefore, actual results may materially differ from these estimates.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Fair Value of Financial Instruments</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company's financial instruments consist of cash, accounts payable, accrued expenses and notes payable. Fair value estimates are made at a specific point in time, based on relevant market information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. The Company considers the carrying values of its financial instruments in the financial statements to approximate fair value as interest rates on the notes payable approximate current rates and the current assets and liabilities are short-term in nature.</font> </div><br/><div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font size="2"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Derivative Financial Instruments</font></font> </div><br/><div style="TEXT-ALIGN: left; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font size="2"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company has a derivative liability which is accounted for at fair value.&#160;&#160;The fair value of the Company&#8217;s derivative liability is estimated at each balance sheet date and changes in fair value are reflected as a gain or loss in the statement of operations.&#160;&#160;The Company utilizes a Black-Scholes option pricing model to estimate fair values of its derivative liability.</font></font> </div><br/><div style="TEXT-ALIGN: left; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font size="2"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">This derivative liability is also marked-to-market prior to any related exercises, modifications, or extinguishments with any necessary changes in fair value from the prior balance sheet date being reflected as a gain or loss in the statement of operations.&#160;&#160;The carrying value of the liability is eliminated upon extinguishment, converted to equity upon an exercise, or adjusted as may be necessary in a modification.</font></font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Income Taxes</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Income taxes are provided for using the liability method of accounting. A deferred tax asset or liability is recorded for all temporary differences between financial and tax reporting.&#160;&#160;Temporary differences are the differences between the reported amounts of assets and liabilities and their tax basis.&#160;&#160;Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.&#160;&#160;Deferred tax assets and liabilities are adjusted for the effect of changes in tax laws and rates on the date of enactment.</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We account for income taxes pursuant to Financial Accounting Standards Board guidance.&#160;&#160;This guidance prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return.&#160;&#160;For those benefits to be recognized, a tax position must be more-likely-than not to be sustained upon examination by taxing authorities. We believe our income tax filing positions and deductions will be sustained upon examination and, accordingly, no reserves, or related accruals for interest and penalties have been recorded at March 31, 2013 and December 31, 2012.&#160;&#160;In accordance with the guidance, the Company has adopted a policy under which, if required to be recognized in the future, interest related to the underpayment of income taxes will be classified as a component of interest expense and any related penalties will be classified in operating expenses in the statements of operations.&#160; The Company has three open years of tax returns subject to examination from 2009 and forward.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Stock-Based Compensation</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company recognizes the cost of stock-based compensation plans and awards in operations on a straight-line basis over the respective vesting period of the awards.&#160;&#160;The Company measures and recognizes compensation expense for all stock-based payment awards made to employees and directors. The compensation expense for the Company's stock-based payments is based on estimated fair values at the time of the grant.</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company estimates the fair value of stock-based payment awards on the date of grant using an option pricing model. These option pricing models involve a number of assumptions, including the expected lives of stock options, the volatility of the public market price for the Company's common stock and interest rates. The Company is using the Black-Scholes option pricing model to estimate the fair value of its options. Stock-based compensation expense recognized during the period is based on the value of the portion of stock-based payment awards that are ultimately expected to vest.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Net Income (Loss) Per Share</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Basic net income (loss) per share is calculated by dividing the net income (loss) for the period by the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is calculated by dividing net income (loss) for the period by the weighted-average number of common shares outstanding during the period, increased by potentially dilutive common shares ("dilutive securities") that were outstanding during the period. Dilutive securities include options granted pursuant to the Company's stock option plan and stock warrants.</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For the periods ended March 31, 2013 and 2012, outstanding options and warrants representing common stock equivalents were excluded from the calculation of the diluted net loss per share as their effect would have been anti-dilutive.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font size="2" style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Comprehensive Income (Loss)</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font size="2" style="FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Comprehensive income (loss) includes net income (loss) and items defined as other comprehensive income (loss). Items defined as other comprehensive income (loss) include items such as foreign currency translation adjustments and unrealized gains and losses on certain marketable securities. For the&#160;three months&#160;ended March 31, 2013 and 2012, there were no adjustments to net income&#160;(loss) to arrive at comprehensive income (loss).</font></font></font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Recent Accounting Pronouncements</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">None that are applicable.</font> </div><br/> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Nature of Business</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Znomics, Inc. ("the Company") was engaged in the business of drug discovery with a cutting-edge biotechnology platform that leveraged medicinal chemistry with the unique attributes of the zebrafish.&#160;&#160;In April 2009, the Company terminated its operations. The Company subsequently disposed of this developmental stage business in 2009 and 2010 prior to it having generated any significant revenues. As the Company is no longer developing any specific business, it no longer refers to itself as a development stage company and accordingly, no longer presents cumulative financial information. The Company is now considered a public shell company with no current business activity.</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company has now focused its efforts on seeking a new business opportunity. The Company is attempting to locate and negotiate with a business entity for the merger of that target company into the Company. In certain instances, a target company may wish to become a subsidiary of the Company or may wish to contribute assets to the Company rather than merge. No assurances can be given that the Company will be successful in locating or negotiating with any target company. The Company will provide a method for a private company to become a reporting ("Public&#8221;) company whose securities are qualified for trading in the United States secondary market.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Basis of Presentation</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;).&#160;&#160;However, certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed, or omitted, pursuant to the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;).&#160;&#160;In the opinion of management, the financial statements include all adjustments consisting of normal, recurring adjustments necessary for the fair presentation of the results of the interim periods presented.&#160;&#160;These condensed financial statements should be read in conjunction with the financial statements of the Company for the fiscal year ended December 31, 2012 as included in the Company&#8217;s 2012 Annual Report, dated August 14, 2013.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Estimates</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The preparation of financial statements in conformity with GAAP requires us to make certain estimates, assumptions and judgments that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period.&#160;&#160;We update these estimates, assumptions and judgments as appropriate, which in most cases is at least quarterly.&#160;&#160;We use our technical accounting knowledge, cumulative business experience, judgment and other factors in the selection and application of our accounting policies.&#160;&#160;While we believe the estimates, assumptions and judgments we use in preparing our financial statements are appropriate, they are subject to factors and uncertainties regarding their outcome and therefore, actual results may materially differ from these estimates.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Fair Value of Financial Instruments</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company's financial instruments consist of cash, accounts payable, accrued expenses and notes payable. Fair value estimates are made at a specific point in time, based on relevant market information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. The Company considers the carrying values of its financial instruments in the financial statements to approximate fair value as interest rates on the notes payable approximate current rates and the current assets and liabilities are short-term in nature.</font></div> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font size="2"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Derivative Financial Instruments</font></font> </div><br/><div style="TEXT-ALIGN: left; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font size="2"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company has a derivative liability which is accounted for at fair value.&#160;&#160;The fair value of the Company&#8217;s derivative liability is estimated at each balance sheet date and changes in fair value are reflected as a gain or loss in the statement of operations.&#160;&#160;The Company utilizes a Black-Scholes option pricing model to estimate fair values of its derivative liability.</font></font> </div><br/><div style="TEXT-ALIGN: left; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font size="2"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">This derivative liability is also marked-to-market prior to any related exercises, modifications, or extinguishments with any necessary changes in fair value from the prior balance sheet date being reflected as a gain or loss in the statement of operations.&#160;&#160;The carrying value of the liability is eliminated upon extinguishment, converted to equity upon an exercise, or adjusted as may be necessary in a modification.</font></font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Income Taxes</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Income taxes are provided for using the liability method of accounting. A deferred tax asset or liability is recorded for all temporary differences between financial and tax reporting.&#160;&#160;Temporary differences are the differences between the reported amounts of assets and liabilities and their tax basis.&#160;&#160;Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.&#160;&#160;Deferred tax assets and liabilities are adjusted for the effect of changes in tax laws and rates on the date of enactment.</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We account for income taxes pursuant to Financial Accounting Standards Board guidance.&#160;&#160;This guidance prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return.&#160;&#160;For those benefits to be recognized, a tax position must be more-likely-than not to be sustained upon examination by taxing authorities. We believe our income tax filing positions and deductions will be sustained upon examination and, accordingly, no reserves, or related accruals for interest and penalties have been recorded at March 31, 2013 and December 31, 2012.&#160;&#160;In accordance with the guidance, the Company has adopted a policy under which, if required to be recognized in the future, interest related to the underpayment of income taxes will be classified as a component of interest expense and any related penalties will be classified in operating expenses in the statements of operations.&#160; The Company has three open years of tax returns subject to examination from 2009 and forward.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Stock-Based Compensation</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company recognizes the cost of stock-based compensation plans and awards in operations on a straight-line basis over the respective vesting period of the awards.&#160;&#160;The Company measures and recognizes compensation expense for all stock-based payment awards made to employees and directors. The compensation expense for the Company's stock-based payments is based on estimated fair values at the time of the grant.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Net Income (Loss) Per Share</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Basic net income (loss) per share is calculated by dividing the net income (loss) for the period by the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is calculated by dividing net income (loss) for the period by the weighted-average number of common shares outstanding during the period, increased by potentially dilutive common shares ("dilutive securities") that were outstanding during the period. Dilutive securities include options granted pursuant to the Company's stock option plan and stock warrants.</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For the periods ended March 31, 2013 and 2012, outstanding options and warrants representing common stock equivalents were excluded from the calculation of the diluted net loss per share as their effect would have been anti-dilutive.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font size="2" style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Comprehensive Income (Loss)</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font size="2" style="FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Comprehensive income (loss) includes net income (loss) and items defined as other comprehensive income (loss). Items defined as other comprehensive income (loss) include items such as foreign currency translation adjustments and unrealized gains and losses on certain marketable securities. For the&#160;three months&#160;ended March 31, 2013 and 2012, there were no adjustments to net income&#160;(loss) to arrive at comprehensive income (loss).</font></font></font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Recent Accounting Pronouncements</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">None that are applicable.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 2. GOING CONCERN</font> </div><br/><div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company's financial statements are prepared using generally accepted accounting principles applicable to a going concern that contemplates the realization of assets and liquidation of liabilities in the normal course of business.&#160;</font> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have incurred substantial losses since our inception. As of March 31, 2013, our accumulated deficit was approximately $6.7 million. Financial results for 2012 reflected a loss from operations of $109,000. We expect to continue to incur net losses as we incur expenses related to seeking a business opportunity and our ongoing costs of being a public reporting company.&#160;&#160;Because we have no revenues, we plan to use our current cash reserves, which came from the cash received from advances under the Discretionary Notes (see Note 3), as well as potential future advances under the Discretionary Notes to fund our ongoing operating costs.</font></font> </div><br/><div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our ability to continue as a going concern is dependent on our success at finding an acquisition candidate in a timely manner.&#160;&#160;We believe our cash position at March 31, 2013 and advances expected under the Discretionary Notes and equity sales of our common stock,&#160;should allow us to fund operations for at least the next 12 months, and through the date a target company merges into the Company.</font></font> </div><br/><div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">However, the current financing environment in the United States is challenging and we can provide no assurances that we could raise capital either to continue our operations or to finance an acquisition. The sale of our securities or the expectation that we will sell additional securities may have an adverse effect on the trading price of our common stock. Further, notwithstanding the Discretionary Notes, we cannot be certain that additional financing will be available when and as needed. If financing is available, it may be on terms that adversely affect the interests of our existing stockholders. If adequate financing is not available, we may need to reduce or eliminate our efforts to find an acquisition opportunity. These factors could significantly limit our ability to continue as a going concern and cause us to investigate other strategic options, including bankruptcy.&#160;</font></font> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</font> </div><br/> -6700000 -109000 <div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 3. DISCRETIONARY ADVANCE SECURED PROMISSORY NOTES</font> </div><br/><div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt">On February 10, 2010, the Company executed Discretionary Advance Secured Promissory Notes (the &#8220;Discretionary Notes&#8221;)&#160;in favor of various stockholders of the Company&#160;who may make advances to the Company from time to time.&#160;&#160;The amounts due under the Discretionary Notes accrue interest at an annual rate of 5% and are due on the earlier to occur of a business combination between the Company and an operating business and three years from each loan advance, or upon the Company&#8217;s insolvency or a material breach of the Stock Purchase Agreement.&#160;&#160;The Discretionary Notes are secured by all of the Company&#8217;s assets.&#160;&#160;Advances totaling $150,000 have been received under the Discretionary Notes and remain outstanding at March 31, 2013.&#160; Accrued interest of $7,600 is also due as of March 31, 2013.&#160; See also Note 6, Subsequent Events.</font></font> </div><br/> 0.05 150000 7600 <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font size="2"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 4.&#160;&#160;Warrant Liability</font></font> </div><br/><div style="TEXT-ALIGN: left; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font size="2"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During 2012, the Company re-reviewed the provisions on all of its outstanding warrants issued originally in 2009 and amended in 2010 and determined that because such warrants could potentially be settled in cash upon a Fundamental Transaction (as defined in the applicable warrant agreement), they should have been accounted for as a derivative liability at fair value with changes in fair value reflected in operating results.&#160; Cumulatively since the date of issuance to December 31, 2012, the fair value of these warrants decreased by $68,000 to a December 31, 2012 fair value of $33,000.&#160; The Company recorded a fourth quarter 2012 adjustment&#160;for all of its prior accounting treatment for these warrants.&#160; No periods since issuance through December 31, 2012 were materially impacted by the previous accounting.</font></font> </div><br/><div style="TEXT-ALIGN: left; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font size="2"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">At issuance and each balance sheet date, the Company estimates the fair value of these warrants using the Black-Scholes option pricing model.&#160;&#160;Changes in fair value are recorded as a non-cash valuation adjustment in the Company's statement of operations.&#160;&#160;The Black-Scholes valuation model inputs for quarter ended March 31, 2013 are as follows:</font></font> </div><br/><table bgcolor="white" cellpadding="0" cellspacing="0" width="85%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr style="background-color: #CCEEFF;"> <td width="30%" style="TEXT-ALIGN: left"> <font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Risk free interest rates</font> </td> <td width="70%"> <font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.95%</font> </td> </tr> <tr> <td width="30%"> <font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected dividend yield</font> </td> <td width="70%"> <font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.0%</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td width="30%"> <font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected stock volatility</font> </td> <td width="70%"> <font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">195.0%</font> </td> </tr> <tr> <td width="30%"> <font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected term of warrants in years</font> </td> <td width="70%"> <font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.1</font> </td> </tr> </table><br/><div style="TEXT-ALIGN: left; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font size="2"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Expected volatility is based upon the observed historical trades of the Company&#8217;s common stock. The expected term of the warrants is based on the remaining terms of the warrants. The risk-free rate of return is based on the U.S. Treasury security rates for maturities consistent with the expected term of the warrants.</font></font> </div><br/><div style="TEXT-ALIGN: left; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font size="2"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Potential future increases in the estimated fair value of these warrants will result in losses being recognized in our statement of operations in future periods.&#160;&#160;Conversely, potential future declines in the estimated fair value of these warrants will result in gains being recognized in our statement of operations in future periods.&#160;&#160;Neither of these potential gains or losses will have any impact on our cash balance, liquidity or cash flows from operations.</font></font><font size="2"><br /> </font> </div><br/><div style="TEXT-ALIGN: left; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font size="2"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table sets forth the changes in the Company's derivative warrant liability for the periods indicated:</font></font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" width="27%" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Date</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td align="left" valign="bottom" width="53%" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Description</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Number of</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warrants</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warrants</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Liability,</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">in thousands</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> </tr> <tr> <td valign="bottom" width="27%"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="53%"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="27%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2011</font> </div> </td> <td align="left" valign="bottom" width="1%"> &#160; </td> <td align="left" valign="bottom" width="53%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance of warrant liability at December 31, 2011</font> </div> </td> <td align="left" valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td align="left" valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> </tr> <tr> <td valign="bottom" width="27%"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="53%"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="27%"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td align="left" valign="bottom" width="53%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fair value of warrants reclassified to warrant liability during 2012</font> </div> </td> <td align="left" valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,686,510</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td align="left" valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">101</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> </tr> <tr> <td valign="bottom" width="27%"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="53%"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="27%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td align="left" valign="bottom" width="53%" style="PADDING-BOTTOM: 0.75pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Change in fair value of warrant liability for the year ended December 31, 2012</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(68</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td valign="bottom" width="27%"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="53%"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="27%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2012</font> </div> </td> <td align="left" valign="bottom" width="1%"> &#160; </td> <td align="left" valign="bottom" width="53%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance of warrant liability at December 31, 2012</font> </div> </td> <td align="left" valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,686,510</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td align="left" valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">33</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> </tr> <tr> <td valign="bottom" width="27%"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="53%"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="27%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td align="left" valign="bottom" width="53%" style="PADDING-BOTTOM: 0.75pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Change in fair value of warrant liability for the quarter ended March 31, 2013</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(17</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td valign="bottom" width="27%"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="53%"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="27%" style="PADDING-BOTTOM: 2.25pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">March 31, 2013</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> &#160; </td> <td align="left" valign="bottom" width="53%" style="PADDING-BOTTOM: 2.25pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance of warrant liability at March 31, 2013</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,686,510</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> &#160; </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> &#160; </td> </tr> </table><br/> -68000 33000 <table bgcolor="white" cellpadding="0" cellspacing="0" width="85%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr style="background-color: #CCEEFF;"> <td width="30%" style="TEXT-ALIGN: left"> <font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Risk free interest rates</font> </td> <td width="70%"> <font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.95%</font> </td> </tr> <tr> <td width="30%"> <font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected dividend yield</font> </td> <td width="70%"> <font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.0%</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td width="30%"> <font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected stock volatility</font> </td> <td width="70%"> <font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">195.0%</font> </td> </tr> <tr> <td width="30%"> <font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected term of warrants in years</font> </td> <td width="70%"> <font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.1</font> </td> </tr> </table> 0.0095 0.000 1.950 P6Y36D <table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" width="27%" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Date</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td align="left" valign="bottom" width="53%" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Description</font> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Number of</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warrants</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warrants</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Liability,</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">in thousands</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> </tr> <tr> <td valign="bottom" width="27%"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="53%"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="27%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2011</font> </div> </td> <td align="left" valign="bottom" width="1%"> &#160; </td> <td align="left" valign="bottom" width="53%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance of warrant liability at December 31, 2011</font> </div> </td> <td align="left" valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td align="left" valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> </tr> <tr> <td valign="bottom" width="27%"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="53%"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="27%"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td align="left" valign="bottom" width="53%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fair value of warrants reclassified to warrant liability during 2012</font> </div> </td> <td align="left" valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,686,510</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td align="left" valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">101</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> </tr> <tr> <td valign="bottom" width="27%"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="53%"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="27%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td align="left" valign="bottom" width="53%" style="PADDING-BOTTOM: 0.75pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Change in fair value of warrant liability for the year ended December 31, 2012</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(68</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td valign="bottom" width="27%"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="53%"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="27%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2012</font> </div> </td> <td align="left" valign="bottom" width="1%"> &#160; </td> <td align="left" valign="bottom" width="53%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance of warrant liability at December 31, 2012</font> </div> </td> <td align="left" valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,686,510</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td align="left" valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">33</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> </tr> <tr> <td valign="bottom" width="27%"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="53%"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="27%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td align="left" valign="bottom" width="53%" style="PADDING-BOTTOM: 0.75pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Change in fair value of warrant liability for the quarter ended March 31, 2013</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(17</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td valign="bottom" width="27%"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="53%"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="27%" style="PADDING-BOTTOM: 2.25pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">March 31, 2013</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> &#160; </td> <td align="left" valign="bottom" width="53%" style="PADDING-BOTTOM: 2.25pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance of warrant liability at March 31, 2013</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,686,510</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> &#160; </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> &#160; </td> </tr> </table> 1686510 101000 -68000 1686510 33000 -17000 1686510 16000 <div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font size="2"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 5.&#160;&#160;Fair Value Measurements</font></font> </div><br/><div style="TEXT-ALIGN: left; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font size="2"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.&#160;&#160;Entities are required to use a fair value hierarchy which maximizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value.&#160;&#160;There are three levels of inputs that may be used to measure fair value:</font></font> </div><br/><table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent-1" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top"> <td style="WIDTH: 13.5pt"> <div> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font> </div> </td> <td style="WIDTH: 72pt"> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Level 1</font> </div> </td> <td style="WIDTH: 36pt"> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">-</font> </div> </td> <td> <div align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Inputs use quoted prices in active markets for identical assets or liabilities.</font> </div> </td> </tr> </table><br/><table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent-2" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top"> <td style="WIDTH: 13.5pt"> <div> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font> </div> </td> <td style="WIDTH: 72pt"> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Level 2</font> </div> </td> <td style="WIDTH: 36pt"> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">-</font> </div> </td> <td> <div align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Inputs use other inputs that are observable, either directly or indirectly, other than Level 1 prices, such as quoted prices for similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</font> </div> </td> </tr> </table><br/><table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent-3" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top"> <td style="WIDTH: 13.5pt"> <div> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font> </div> </td> <td style="WIDTH: 72pt"> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Level 3</font> </div> </td> <td style="WIDTH: 36pt"> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">-</font> </div> </td> <td> <div align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Inputs are unobservable inputs that are supported by little or no market activity and that are financial instruments whose values are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment or estimation.</font> </div> </td> </tr> </table><br/><div style="TEXT-ALIGN: left; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font size="2"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.&#160;&#160;The Company&#8217;s assessment of the significance of particular inputs to these fair value measurements requires judgment and considers factors specific to each asset or liability.</font></font> </div><br/><div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font size="2"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Level 3 Valuation Techniques</font></font></font> </div><br/><div style="TEXT-ALIGN: left; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font size="2"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The warrant liability is classified as level 3 within the fair value hierarchy as its fair value is measured using the Black-Scholes option pricing model with several unobservable and estimated inputs, supported by little or no market activity.&#160;&#160;The Black-Scholes valuation model inputs for the quarter ended March 31, 2013 are as follows:</font></font> </div><br/><table bgcolor="white" cellpadding="0" cellspacing="0" width="85%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr style="background-color: #CCEEFF;"> <td width="30%"> <font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Risk free interest rates</font> </td> <td width="70%"> <font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.95%</font> </td> </tr> <tr> <td width="30%"> <font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected dividend yield</font> </td> <td width="70%"> <font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.0%</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td width="30%"> <font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected stock volatility</font> </td> <td width="70%"> <font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">195.0%</font> </td> </tr> <tr> <td width="30%"> <font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected term of warrants in years</font> </td> <td width="70%"> <font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.1</font> </td> </tr> </table><br/><div style="TEXT-ALIGN: left; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font size="2"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Expected volatility is based upon the observed historical trades of the Company&#8217;s common stock. The expected term of the warrants is based on the remaining terms of the warrants. The risk-free rate of return is based on the U.S. Treasury security rates for maturities consistent with the expected term of the warrants.</font></font> </div><br/><div style="TEXT-ALIGN: left; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font size="2"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Significant increases (decreases) in any of those inputs in isolation could result in a significantly different fair value measurement. Generally a change in the assumption used for expected term is accompanied by a directionally similar change in the assumptions used for expected volatility and risk-free interest rate.</font></font><font size="2"><br /> </font> </div><br/><div style="TEXT-ALIGN: left; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font size="2"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The valuation methods described above may produce a fair value calculation that may not be indicative of the net realizable value or reflective of future fair values.&#160;&#160;Furthermore, while the Company believes its valuation method is appropriate and consistent with similar instruments, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.</font></font> </div><br/><div style="TEXT-ALIGN: left; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font size="2"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Liabilities measured at fair value on a recurring basis at March 31, 2013 are as follows, in thousands:</font></font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" width="60%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 0.75pt"> &#160; </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Quoted</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prices in</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Active Markets</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">for Identical</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Liabilities</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Level 1)</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Significant</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Observable</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inputs</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Level 2)</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Significant</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Unobservable</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inputs</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Level 3)</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">March 31,</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> </tr> <tr> <td valign="bottom" width="60%"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%" style="PADDING-BOTTOM: 2.25pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warrant liability</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> &#160; </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> &#160; </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> &#160; </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> &#160; </td> </tr> </table><br/><div style="TEXT-ALIGN: left; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font size="2"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Liabilities measured at fair value on a recurring basis at December 31, 2012 are as follows, in thousands:</font></font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" width="60%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 0.75pt"> &#160; </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Quoted</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prices in</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Active Markets</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">for Identical</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Liabilities</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Level 1)</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Significant</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Observable</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inputs</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Level 2)</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Significant</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Unobservable</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inputs</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Level 3)</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December&#160;31,</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> </tr> <tr> <td valign="bottom" width="60%"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%" style="PADDING-BOTTOM: 2.25pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warrant liability</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> &#160; </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> &#160; </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">33</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> &#160; </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">33</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> &#160; </td> </tr> </table><br/><div style="TEXT-ALIGN: left; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font size="2"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There were no warrants transfers between fair value levels during the quarter ended March 31, 2013.</font></font> </div><br/><div style="TEXT-ALIGN: left; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font size="2"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table details the activity of our warrant liability measured at fair value, whose fair values are determined by Level 3 inputs, in thousands:</font></font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance, December 31, 2011</font> </div> </td> <td align="left" valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fair value of warrants reclassified to liability</font> </div> </td> <td align="left" valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">101</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 0.75pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gain on change in fair value of warrant liability recorded in other income (expenses)</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(68</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance, December 31, 2012</font> </div> </td> <td align="left" valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">33</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 0.75pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gain on change in fair value of warrant liability recorded in other income (expenses)</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(17</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 2.25pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance, March 31, 2013</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> &#160; </td> </tr> </table><br/><div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font size="2"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The gain recorded in other income, for level 3 liabilities still held at March 31, 2013 and December 31, 2012 was $68,000 and $17,000, respectively.</font></font> </div><br/> 68000 17000 <table bgcolor="white" cellpadding="0" cellspacing="0" width="85%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr style="background-color: #CCEEFF;"> <td width="30%"> <font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Risk free interest rates</font> </td> <td width="70%"> <font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.95%</font> </td> </tr> <tr> <td width="30%"> <font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected dividend yield</font> </td> <td width="70%"> <font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.0%</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td width="30%"> <font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected stock volatility</font> </td> <td width="70%"> <font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">195.0%</font> </td> </tr> <tr> <td width="30%"> <font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected term of warrants in years</font> </td> <td width="70%"> <font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.1</font> </td> </tr> </table> 0.0095 0.000 1.950 P6Y36D <table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" width="60%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 0.75pt"> &#160; </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Quoted</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prices in</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Active Markets</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">for Identical</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Liabilities</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Level 1)</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Significant</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Observable</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inputs</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Level 2)</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Significant</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Unobservable</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inputs</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Level 3)</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">March 31,</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2013</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> </tr> <tr> <td valign="bottom" width="60%"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%" style="PADDING-BOTTOM: 2.25pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warrant liability</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> &#160; </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> &#160; </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> &#160; </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> &#160; </td> </tr> </table><table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" width="60%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 0.75pt"> &#160; </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Quoted</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prices in</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Active Markets</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">for Identical</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Liabilities</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Level 1)</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Significant</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Observable</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inputs</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Level 2)</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Significant</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Unobservable</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inputs</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Level 3)</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December&#160;31,</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> </tr> <tr> <td valign="bottom" width="60%"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="1%"> &#160; </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%" style="PADDING-BOTTOM: 2.25pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warrant liability</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> &#160; </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> &#160; </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">33</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> &#160; </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">33</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> &#160; </td> </tr> </table> 16000 16000 33000 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance, December 31, 2011</font> </div> </td> <td align="left" valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fair value of warrants reclassified to liability</font> </div> </td> <td align="left" valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">101</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 0.75pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gain on change in fair value of warrant liability recorded in other income (expenses)</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(68</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance, December 31, 2012</font> </div> </td> <td align="left" valign="bottom" width="1%"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">33</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> &#160; </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 0.75pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gain on change in fair value of warrant liability recorded in other income (expenses)</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.75pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> &#160; </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(17</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="90%" style="PADDING-BOTTOM: 2.25pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance, March 31, 2013</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2.25pt"> &#160; </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> &#160; </td> </tr> </table> 101000 68000 17000 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font size="2" style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 6.&#160;SUBSEQUENT EVENTS</font></font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font size="2" style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: normal">On May 10, 2013, subsequent to quarter end, additional advances of $25,000 were received under the Discretionary Notes and remain outstanding.&#160; In addition, on July 1, 2013, the stockholders who have made the above noted advances contributed $50,000 in exchange for 2,625,996 shares of Znomics common stock.</font></font></font> </div><br/> 25000 50000 2625996 EX-101.SCH 8 znom-20130331.xsd XBRL TAXONOMY EXTENSION SCHEMA 001 - Statement - A Development Stage Company - Balance Sheets (Unaudited) link:presentationLink link:definitionLink link:calculationLink 002 - Statement - A Development Stage Company - Balance Sheets (Unaudited) (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - A Development Stage Company - Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - A Development Stage Company - Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 005 - Disclosure - Note 1 - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 006 - Disclosure - Note 2 - Going Concern link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Note 3 - Discretionary Advance Secured Promissory Notes link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Note 4 - Warrant Liability link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Note 5 - Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Note 6 - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Note 4 - Warrant Liability (Tables) link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Note 5 - Fair Value Measurements (Tables) link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Note 1 - Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Note 2 - Going Concern (Details) link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Note 3 - Discretionary Advance Secured Promissory Notes (Details) link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Note 4 - Warrant Liability (Details) link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Note 4 - Warrant Liability (Details) - Warrant valuation inputs: link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Note 4 - Warrant Liability (Details) - Changes in derivative warrant liability: link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Note 5 - Fair Value Measurements (Details) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Note 5 - Fair Value Measurements (Details) - Black-Scholes valuation model inputs link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Note 5 - Fair Value Measurements (Details) - Liabilities measured at fair value on a recurring basis link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Note 5 - Fair Value Measurements (Details) - Warrant liability measured at fair value link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Note 6 - Subsequent Events (Details) link:presentationLink link:definitionLink link:calculationLink 000 - Disclosure - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 9 znom-20130331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 10 znom-20130331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 11 znom-20130331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 12 znom-20130331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 13 R8.xml IDEA: Note 3 - Discretionary Advance Secured Promissory Notes 2.4.0.8007 - Disclosure - Note 3 - Discretionary Advance Secured Promissory Notestruefalsefalse1false falsefalsec2_From1Jan2013To31Mar2013http://www.sec.gov/CIK0001371473duration2013-01-01T00:00:002013-03-31T00:00:001true 1us-gaap_DebtDisclosureAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false 2us-gaap_DebtDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 3. DISCRETIONARY ADVANCE SECURED PROMISSORY NOTES</font> </div><br/><div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt">On February 10, 2010, the Company executed Discretionary Advance Secured Promissory Notes (the &#8220;Discretionary Notes&#8221;)&#160;in favor of various stockholders of the Company&#160;who may make advances to the Company from time to time.&#160;&#160;The amounts due under the Discretionary Notes accrue interest at an annual rate of 5% and are due on the earlier to occur of a business combination between the Company and an operating business and three years from each loan advance, or upon the Company&#8217;s insolvency or a material breach of the Stock Purchase Agreement.&#160;&#160;The Discretionary Notes are secured by all of the Company&#8217;s assets.&#160;&#160;Advances totaling $150,000 have been received under the Discretionary Notes and remain outstanding at March 31, 2013.&#160; Accrued interest of $7,600 is also due as of March 31, 2013.&#160; See also Note 6, Subsequent Events.</font></font> </div><br/>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19, 20, 22 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19,20,22) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false0falseNote 3 - Discretionary Advance Secured Promissory NotesUnKnownUnKnownUnKnownUnKnowntruefalsefalseNoteshttp://www.znomics.com/role/Note3DiscretionaryAdvanceSecuredPromissoryNotes12 ZIP 14 0001171843-13-003427-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001171843-13-003427-xbrl.zip M4$L#!!0````(`/EP$$/^!DS*.T<``+SQ`P`1`!P`>FYO;2TR,#$S,#,S,2YX M;6Q55`D``W5J#E)U:@Y2=7@+``$$)0X```0Y`0``[%U;<]LXLGX_5><_8+U5 M4S-5EFW)<1([B:H47S+:26QO[&QF]F4+(B$)$XID"-*V\NM/-RXD"$)W.9NS MZZF9B<-+=Z/1_:&[T:!?_Z75(N]8S#*:LY`,IH2?_IQ/?B$M(*U6E^`___L_ MKY'):<:0Q0FY'1>D5XQ(^XAT#D\Z+T^..N33[2GI'+0/U4OPQL,@B\C#)(K% MFQV+$5[>2[+1?N?@X'"?QR*G<)>O^'Q8O6`__'Q?W32/?HN328TR M7N"!'.D^2GYP>-@V#X?,(2I8L#=*[O;AAGRX==!N58\7HC6B-"U?&5(QD'+H M&YY7(AY_F3-0O#V@@ED<\FG*A)>%O./A\1#-X?#[>V!AGN0B>=9IOYBG>?6$ M>4';2_F"SWXJ,=RQWA]*PNWCX^-]>;=\5/B>`P':^[]_>'\3C-F$MDHCZ"KC M).0UTC@1\O9'-B22Y@FJYJKQ8MM#/I% M`PM^W'5C`RS0;K$A%KQ4RKH*THZ[@>?/WK@O+L M'S0J6#].BUR\9W>;@WZ][^7J3,Q^*>Z_ M/[`\J$>6BV;T:4H?;4JW%3:WVT[GV7[TV7ZQPFR_6'/] M+6*NIKH0H8W`$T9%D;&NK@&=?+HY>[UO+I**'KYO_=TF=\TR,:89$Y91A/P. M9K,V:GSELIA@+3/)NL2>S(5"5"IWJ=3IGS$L_,7FGH^'+$.>*($](ZVXN+1* M75=C6Z";4BN.KF>(,)]8"L_48LDZ-;S=U%F3G#;Z4RK&O3C$/\Z_%OR.1F"Y MHI>?TBR;\G@D5S&"+W_$HAH:#=$F)2\TZF$"P72_!> M;<9J9-=GNF#`AZLSW?80NPW?6,QGG5%Y^`1!4H"-7=,I'43+F,^"\=7-QT_> M@P6KR[%@_$=KRY$5+'S/Z8!'/.=L"U;]K.W*XF?1W88LB[Q[35FVJY#ZY'BY M;\)^D0Z>K\K^K&"WR4<6X?;D-41(\.AE$@<;2](^JGOI7#X.[I]!M'5'<<]U MJW/3KBMG'I>FFM84:1&4':XODO7()J#=;L\R&0^&+,ES46C0.5Z!YVDRF23Q M39X$7S8-FX[JZG8I-]>057@O0NU5>4-\,F0P]>%6AEX/?%S"S7YT]+C#DP8_3J(0LGE,@/+I!K/1:A_74;M)W6-`JXFP0&,@PO'J(EA( M#\G@5G7B9!^+.'6W)]AJZ*J>NQ?7NQTT2D.9JWT M+J]&3+>^7'.4]AAR]84H-M;54>>H??SR^/DYQQ-N>2R\0S'69+4JV2'.;2';#H@ANJ)[Z".*;7CCA,1=Y)JL:NM8^+YB: MW4[JA%7U=&0YQF[I;W-Q9S=TNL6G9^O)6Q?X*L6=.7BQ'P?)A+U/Q-PZS-+* M;-6UZ6'C`>X5A5E:52U'5UYI:I+(4QI,Y-NTKTY-!H?#^OR7-Y@5^%=UPW>4 MQZB@J[BZ=LGFEBB7UDC;K0`L8-JPWLLD3NISNE64-S12O)Y]7=+'[1^ MWP+2#OEV%->0JL&FN3*N(<_2JEI''O#/+:\A=7.JT6^XW++,U[86E[TCP#G- M8O!`80+GMU3P`%;A,QX5N1U[SHG?EU),1T7RE6`+.'>W+^=2.EQ33CP-=O*9 M\=$8KO7N`-A&[++`5JXKYX55H]2EM.LDH!M(\^CC66H6MCZ>*I!/``4>R=4K MXFMQ7=O';;YN8*]-EH5XD!>`D.(>RR/$97Y&GF`9T"AC%+?6Y$I_H M)!!:6NYE&D2O92>T.X./H?%5^"_=@KNZ^&MK?C7YM]N;ZQZ==;A5$ MX1-G25!,]`F(I3FU#UI_5PSLU^N$=?_7!1*88U`ES0& M#G@_D@BB`YI-+W@$N>/2'"\3FZ%#Q>WB_^N0 MX%":R4LM+:MQ^WO;Q\NBU/5AG+J_*@YUK`.Q,ZDU4SD^BOF0!P"Z.IX%2[A. M\-08$[?`]VT$F+&T$#]%^:N0WQ&13R/VYJ>O19*_NCW__;;5OSP[O[P](0=I M_HJ<]6^NW_?^."$#)/Z*?.A]?->_;+T_OS!/Z"L?^^]^59<4*4(CD%?3C=A0 M7_YI!/_]]2%\59XO(@0E&8+4-5%*QCR.>,Q>D8NKR]O61>]#_SU]/]Y?D+:I0R2V?+$/Y^K,0R2**P(7%[=GI/V'KGY]`&&^H<1 MOA+_ZH+<]-]=]B_ZI[W+6]([/;WZ='G;OWQ'KJ_>]T_[YS6J0[9L?_[T3M6"JE.YO_W@/RL>631Y8XJPU??,G!'`\8TW9DB%Y M6PA@)H1'QYNI^/#Y]G3\9R%R/IQZU/Q=',+$=*X78HA'?E;/Y6-FEAAUX1=R M3P5A\8B.6`@2$'QBH+6-F@^S8N12#`%"DSL&"]T]S\>$DJ#($;-:+!S!VSS) M63".DR@934D:T7R89!,@3/.&0B*F:GXAF;`0\"ZF$<'SOAB#:NHH$`1C7R'6 MIGI;A*%D]NP3^=0W-LCHD(OQWD]TDK[Z:_OYP:OJIWY,>FG&(P)A]_$NL35A M^RJ08ID\M8GZR(&3RB.36.R1V^HE(LI3O]$4-9(FD'8ZI$!_^9@+B`[+SED8 MH)"MO*620>DH$H%($#^2=T!`RB1SAI>`+&1,[S!&&)7?\Y-R5*L'R8!/7#"0 MM"=PA(XX1G20*$Y(E,0C//&L9$/"DEP*D2R0*^7;1G0 M)8Z5WDGA9EX:#H^!J84O>P#!)&!93L'5S?<)P:^H.R2'SH2B$8HQCF'`<*L/ M!$38X2&';$0)XZ)8I9^L1@"C1P6>X*/R>&I=2`*(,F8X6!K7L4<.?8]<)OAB MD4GA"<`-R$1&X)2Q5$F-UCV/(KC=='51!/"V&!81PIZ<&)PDD-7,!/Y5S070 M40IID@F,8F]=IJFJ`H*B)BP?)Z&<0(J0>@>S[.K(:-I6<%;F8GK-O)9@H1:2 MEYU.&];,$B+&`/IU;0D&>*&*G=@F^;4`EQQRI@2!/%D6%_0Z^PF,%^[(-D?1 ML$V@E,0A3O2$9E]8_@APL\4`T'')9K.(0N$/(P`(L4=[\R&6PZ,`KFCFLXPJY"@#(91O\% MDFD$(JKH)X*@"^ZS-+XQ--UU12Q1 MO(PV9-PV3)(\AK!7AL91@I_0P"4NP_K.M(E?,)BH"%7`[567I20='B'L2K4X M$N%H+.TB9."N8KB+H`H)`:R$\'-:9*+`"%&#?E9$!G'*.81A9&PD(RV(EG6FE0JN$A$:HI.HZS+R$VA&]0$#'S5#NS!N#/)DS&&]&#-**"]5R+&SD4^(^L2.\!-@H5/_/(@ZDC&52-9M4+7VI%MA2"[*"1J:,9A`FH1F?@:;DYY,.V[N8 MPW0@5'"ELFW>#ENT=;1?O!+JU5XE;2$,JH!Z6`%55'%@*59J`KTMDA+'O$OP5+0";L3NX###S#I,Q5=>I)Y,#P`5G@:S&O%='U=OZ&F5C M$V(\"!+++34Y2A[?)=%=$T;K*(5/3K!\FLE5UMY#.8B%I4'0**8?(5-[ M*:`%&?4`!`=KE'@;04PU0:DZD6%@P]ML$;VA[9KX(49:$]P>I M/9G;*196\F*G+^IX&M9)F2Q3(^&:Z=3(F5V#S*[MV;FV')I^J`JCZF$3SN<8 MHI86ZM$S-C6]6RP,]M[WWUV>$-PM?D6V"//^36<;5_@W(TAGP1[_=\;[ZL"? M`P=D&;2?E4UMEOTQ-E"W,,J!J[BXA M0.S*TV>57&PP4/E*`S:)MX#A%0Q$,A@=(G]&@['/&08TDE4^,6:P*H1ZSXJH M@IN,N&V,RC"K&V+TW=AV)FH;=H2Y8Y*1*!%5O&[PK[NR=[EEZ,=-0Y#"T M;PA1Y&U$@R^MFV"<-$J*2%*N:A!!!XC@DR1D$0*OT8V`9K/R8JH$)R(!" MVIDL4K,'3`@++L8Z92N+W)8]@\U5Y5B_1Y@<2(NDO:DAD^5=`X9&67K13*_Q MF:3M2,MX3CV**;VO1A.%K\-&Q$TK2I&"']55M8N!DOQ]C4T`0!_3G_5*97)> MSH'4N2ISJR%C1@G!6JG>IHGB)D1MXA;Z'EG;^[YG6OEC)9;J-&]3MEOZX"W+ M5L\\Y9`UY57M%`\ZB-9=`6H3'BM?(\?7=+.`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`STMWQ_P=Y^91H%#2:+1/C"C3<0QZWI?C,0Q MXPNU_FY5-`@3V2M$'1W+?2C\^"VD/:J$`"O%T&S'A@W[J:\YY4P56(C;M:J$ M.O/1_3:2?$JGQBULC'!(F4D-(E@-5.N@S$NPPRJ)R_ M8:.\QSAE!U9V#WCYU"2Y<1XB3ZBVY!<_FJJVOP'R%"*LU_Y>@HG>WTC4'I:0 M>E>;1H']39RT"A\E_9MX<+)Q[AQH_JM'`,*A@G>&+'7\T`)$GU MGM$=$U:/A`EY%:-9M0V_E<@.=A4,Z.BS&G9M>`;"ABK,=N#0UHH!4#UNN0.' M*#%)HV3*-)L08%ONP3O_7M=$)M&E;<%F/5)VE*%&5L'(%WBG)@FI5NSP+Z-)<% MB,8JJ_Q7GW>J2K;!3+,/Y%<*-!=/;UA]'[1Q\J8JKM3V!;2\S>ZY6?L"S0E5 M9_%TL.'0N9D%G<;'K?BM:A'3(.=IQ2K=6FK7V@:J2@)S+,PQ,-6+AY_,CM3@ MHFDMY4'(G=&:\Q2XK'1^F+DNKJJ"Y&?\@MHOY!I\3WYY8T[!^@EPY2&9H`EQ ML>Q44?J,I#Y3_.V\\F/P'`^$18'Z93&8]>J"6;I86'>J;ZRA&R:W4])CJ<9=;\@C!\#O3IY?=2MO%N=8M/'Q'T- M/P!K]PQ;@I=0N4/4M^29]5.H-1A1U3FUXHO0'%)F"8:064:#:AT#($:2W@[( M)[\WC8W-_8IJ&H4^Z>&IWF#!9MUCN"$E9_+G=PFK'I\IJUG-S"OG+>,I M_T$+=Z/]8.%:OKVE&ST[8V/\U>N>%L7:,OZT>*^HV^\4FOD8+F]2ZB3>9L-6 M-.8:E7^UU^N/\,0XLG,V_[_VOH6Y;9M9^Z_P\\F92:>V(UGUK2?QC&,YJ=O& M0!"5:EF3*7L\[;Q5=P`6P=^P^8&,L M[1J*%'NYLTTV1ECJT_*C;!MGA2'D;TJL,66,U$A*:G@$:M@4Z7AP*,H]F+*R MU+K'EG./Q[I1;6Z4#0K)T:2H>JGHXX&GRX+7I!U)AI&BXC4SZ=O&A_C(*$T- MY?*^V8"@Z\,1S[XVP["(PF*I^4LH).J$P$=0/+)T]'CUL$`I"'!5S8+C-VW? MII2Y/!NU_W3QVB6SLJR,0EMV.FI192002OA5=7!-M-(+RZXI!:.(7'GBT0&7I#%7]AK1#O&B!&>=@T)3`FT#0" M32/0-`)-(]"TM5%'!)I&H&DE42?0M(6!IBD:)O-G'^Z9:BYCB+]><(COY?\W MVZ4MZ[P&>+4YJ#;%-2"D-D)J(Z0V0FHCI+;""JTE4IO>'ML,4 MQHP,+2&_+=>2$O(;(;\1\ALAOZ4CK0_RF];JYNUGT;HB*)9`.>L-TS9&!?1& MVF8RN@\'D4OVBB#D"$*.(.0(0JX1$'):`U'+!!3M1H:>QA>>"ETJ6-TFT;DVUAU+T960;0M^\HT-=@KA; M?8Q+$'<$<9?5<1'$'4'<+5/;$,0=0=P1Q!U!W&4[11!WC82XTP8U5:'*43)F M&M0(0!0!]J9"N_62*E@8"(NZ;]@%@I#1,=]CH?34TRG"T2,A=A%J5VZLI:!V M:1V%&2;^J.@2Y-"&I`E[%BV`S8,%TSL*Y!X0+ACA@A$NF%#V#<$%TQJ6NH:B M7$J9MJ?WAL#\2G]<#B7KW`^_LO`X3@:OF;5I#!I9P@8$1K9:,+**&ITY6/]( MBL]WSQ___-&'[Y[X6*?><'RQBEU[*B?AO-<_+=JUG6WC8^_L_*-QTCL_.;T\ M7UAX%I12B,,8LZ\0V/(;7M?FI9AY/T.*`'!@^(`BXR MN$D3HIH*K_;?E[Q1JZFC4&8C@E38ITA4Q2`X46B*5$_B5,'B6.G!.9M(?*[C M,H!;WCG:3#HM9;,GWG4!CJ7EA`*N3NDL<DZ,\;UZCC(T7K5;AYNM5DN4!*N?/&?A5#>`KV=(*(_E>(A)3SMZDGP?;T93"!=E!8)ECIB90>!%C M)``G!KS*.,MBVC<2>$H>_>-ON@Y84H8[@Q5TYZ+WZ#5G94N-'QF='S;EVB-0 M!\]2DG$Q@.8!!7ITCX/]&D:%+4@/YXL^."^E_[1NUYK8F_569;TH*.LR88CB MTE!5IF7!NFIR#('I.,&P#BL\-'5%0E"!*V+`,]$0X\@,-2:&+;`Y<1&3A3E+ M4=&'153ELG!#G!6ZV##M@>VL:J=72Y2$P*554L5HL*QMY5)%1) M@P`QD.7PW'1EJXD@1Z17RT2(?.MF-HL80D:4C<8($E*Z,@TL#H1+ASGX)U$' MY&G/76B`>I=!>`+'$/C1]2BKGC1SV'+J0"GZ'L+>\3*87VT1;K(8/P\I+N!E M%<5&:2F-W5.LF/)N'`BT1-&`#H;/*$.U":X8`5LR[UH*L(WF#R$0$[A!+P>. M&)],:<<1+!Z8#@(LF1-,!AC,DCV;&5>=B@G(\C,N3*9MB['1P2^+\!60(AOVAF>5SG*Q M$PA$>7.;I$^_?^JI#/AQ48"KA$60(180I@=^)5=`,S^AGS;C38O;L9-4GXSC ML^FEK*(U>4E!GGEC.JX(2+"V72I03*XRF]G;QME0X3BG[%CB7SJ"J'6/VX-P MD5@P3K!OY`HBZER*@E->\Z2Z,-6W[$XBC\FEP^)A&$409=J@GS,<3'44E5Y1 M/ZO0=\L$?3@[Y#I9[F^43^OP+VVFDJ3$J*Z25^VB[5,Q7'6#R9;^!(Y$RH[2 MA`\+@T\+9;"06NXJ=JHVYZ(!5/BZTNPXGBAZNDZ7*F?6A;1B.57(KL&W3N\O M3*\[U!,P,+U_@V@26O>5H:+ZCY5%]%H^R`?RMB]8(@6[0R1G-2]=AL05R@`+ M#>*P*W/U$\B8!!L[0US0`RK7,*=OWU1GQH[RF>=+)FNODR/1XRS$[,81)K*C MR*-%W-[()]9:?Q_SWC!+IX$3:$$8ZO)W&UN[&T=;>_LM_,NR?;,?5SI\O0C\ MH1/B.>`T2O;5%-\.IOBZS,*7*DTM(`GBU1Q%V?"E)W?9(.RF(%F+1S?0>S4+ M`#AH7%JQLXTS.KD\[9_USH\OOQK'W2_'YR>GQM7IR>?+TZYQ<=G[='9UU8./ M\/=7:QT*-L6!U`9ZGO&!#8((HY1VJW0W`N+MY[L/V!VX-^@.YB.<8QD=2632 M,C0D2!4"D_I9(@+'5"!)=1Y*+D'!5<32S#Z(YNL;7R"/WYB!XT<\9]8K:DAS MJ`DXSNW(CU&W_E5R'04(<*FC'5U;*WX3/JALO$[:#^V(5:5HM'D9'H,0*5TJ MH?`2)!YG$'>Z[?ZW=+$")I[@EY.^X&>:`83`PH_V+4RO89XWPX@#HS-(.WVR M#LKJ2F79I*$T6V07`,B(DK&X)4*L6X8WD1TK2R]8MKA@+^O$KX8A=3R.B$1X MH(U!;G%'$[@T8Q#@DU*D7%&S=!%!.&_R2#^-@[7\Z7 M9>NS]DK=3&1R7?O$6(Q*(5;HXZDHK/&K]FX+\ZOY]B29")S.5P6N$M7E8X$R MH%0'`G/E4Q]J)\RQA,,JU0;&C(G9W_W-/:`M@6FPI3<)'U0.6MJ1*\;DCT56 M.=C:.6MNMW3QE]1ZIJ5CO1JSO7\J4^8498"1Z[GM)J#^?^P:N M$G!>SE.:^A@-6DF9B3^I$_FRAI5X_<$I^`!&4="X:GT!+NB M,%P35*8U6$HWUE;`;AQVR^P8ZL:_$4A]LI5*6K\,1"D;2C4U::DQ^(4(LN@' MSC7>;^7>YVY\,L>B.*PTE/A.NQ4W$:?(@2(O-(@/YD2%7/H<$$KG&^`#6U9075)7WK8\5=J:$R'UM9E5^<0)5.9Z/J2D/82:> MR`\Q!FV<[<_L?`Y03&1IBO*BQ4S*08W)WN("27LP/@7%-M?%"LN@8G M*>BPYL#9B`^Y56@&W'01,(`W6FJ8WBS@^A?IDKX59]G>@BU(VRN,5WL'PD42 MI1#)X"4&2E'Q\RAKKSH=<7Y=T0&<]((7"3-A4S`#F^`ZQX#[:1(H&VZ8X6\X MXE*)TF5F.63G$.8E1DC:591IJT2>^X6K##0;D"UZ?-Q3OB)`%%EFT,.ZL1Q8 M"2ONM9'2#[H`XRX%7(90T1ZMCX\U]SH9V1:*PT0,=,IX?86`/07]+TTOD;)* MLGG"=!A[6O-]4@4DJ!LU@U[`I+3G>UM")RL8.JF$%5'2LD%*74D/ MPDPKRF9N)11*)*J@XTVBN(8FT02J_5+&*1XQRSZ7H8^GN_SG&CY-'2&2)=J# M:\MW_2!FT-N1$[*X'-%BKCO!PQWO.OZTI7S"0=#+G]PZ=CB*WSO8_>_*JOZB MWY>(0"A$`*^N"U`$2O)7/'L-@]S@`UC^:U!?GKTE9O6S\5\G)Z>G'S[\3U7& M4QG*SE'?:>FH+RJ:Z6YT45$4EZ%BUE,$_]+A_U8_:8AIE3R\<#6H@$K>F]"N M+%31KLY^LCJKFWIK^Q`8:L8A1YT)R<^#J5PU#Z.L;BE.XRJ3B@4P9)LKZ!;C MWF'@USXC'FCI66#Q'+!TO=(@=I'-FS<^>NGEH'D^*6L*R[0/=ZN8AA1'Z6$" M'1Y&(O>WVXS7B-%Z0GZ%WU:30I1F12YX#E>`]53X9#DQZ MY.,/1/VS;8P<4%4!7G@D:J&4N\P+D8ON:"5?$]5/R[8P,Q2SO:9&2$E%9?`T MLBL"3TA$#"2JCN)#G2S^+@R$#PS`?=L27EIR.">AP$J#?]Z^`A(#@?=3+LJ* MJ\CN8YC+H;BN.$RJU.++3#"(2='B6%[PE<7*9EX%M$`1^AQ\?I$D#DLK'M?, M)Z`?:7.,#O(H#;M+HZ1L*8KJXCHA<2VTZ)1(<,-5+#^E6%!A)7W`*R)P06CI MR7$F21^_"[1OK+K;+'<)V,S")=55]-59`NV4BT(&`\E6Y8H%F#+?\MK$=$^; M\'E89L#`+C3;5@59E/T@D/N31$IG2$$8D;YF6"*%;;*KQQ"4)'(T=* MDC^6%B79GX]_K]WB=D<(@RC=;V_NX$(;I=QRY2K?.*5]60 MK,UV%0F:JYZMON?>Q9KBF:Y[@24?E>]XU*ZW=9M^<=SMGIU_3'==[O>4"L&4 MHG)=S)/,:K=#O+P(7LZP#.JD6Q;)U$OGWB6RKN6CQ?#REMOP_-O`G,1ORG\\ MB*U+7JKENA!3]?3B)K$4 M/;(V/BGQR@ODE547-BTF*3[3KWA9><%<3X+F\7%9L+:(I>FI\!6)\V(2W,27 MN8ME])>5)W]9T5B^OZC81J)C6V+:1^:&UO[AWL;>ZV6_K*BA=N'DFJ2*KFDJJ6_D3LA8L3I86:)TV4 M%B*52>$S\37Q-?%UX?/&IH7F:6)]^Q40`> MU=8T)3`*"(LU);$ED#W+(+KK6+37N/[UI^T#:<3DY@.4R$_NZ6/VQI=Q-+)M MB*2;I'L=I/OUWD'S,W++D/!E+NH/CU>9E!)LGL132I!2)Y0Z(;XFOB:^+GQ. M[9QKG&ZJW8]LYJ="NBE8R^D^>@*!".Y(JDJI%2U6G4\-5 M>6G"1#FUYLD2Y=1(85+N@?B:^)KXNO`YE=E1F5T]WX'*[)ZVS"Z^*;MR%K+. M+G]A=JUPOW%Y*2K$61,KO':%.%1F]_3Y,9)NDNXEE=FU]ZG,CLKL*!]`*4%* MG5#JA/B:^)KX^B'S6<\RNZD!Q<[V#B6FM(Z=R!15+X5;`3,ZZ3/[WS,L>D-Q0#(,9D>>$EVSX;B/B]H9AP;;# MH.(-:__O#\`M[5]-#]LI^GZG#8/ARPW#9I8S-EW^;J.U<;2U=]!JM;*9U'RT MANCL>PC._`7/X'O#\H_OC\<0XH;G?M@;#CD+CZ]-!];LQ'==,V2!Z4Z;5?OO M8]X;5LVET\E-95$$:>::#O@)U@@V4^RW+$[@9QY^`H_PO3ZS1I[S+8*MRDUC M1]V<#FX..,?X*"E9X%F9TV;SBX\!!?!N/'!%LEK"A9Y)O_$+-,^W*UB M&E(!Z1CGKK1P/($6J+4C:\H1>]M:M/5E^?*9K_A@A^[(J'()CSF/QA/\ M-D>7X`,8_K/8[E^"V<_%B6,H/=V.ZNG^M'$$RK9UN*LA M?\;#:U&=<&(WME2+H;HCJ6Y-)UKW[*,'T/PE590+H[H-SDU-JO-//ZI/=A]E MNR9U1Q=[7SM[W7H4X_K^M+>-___STY:?_^]^_K$ET]]7;/;2_[]]< M?[WW/G>CVX_[P>'^;SO_?.[?^]B?'#L_W7Z_?*7 M?[X?O)]\.__/2>3O'T=_7K;M0^?TK-\]_77G<-+O_7;VV;YQV6GW8W\\QKL'_XZV;?X[7]V3M_87P/W^IC??1I].;'W#_YB(+X[M[TOGPX[K3^N__KQ MPCWYYX]?W@P[@[^^[?BCS[]W_]/_^.W'WWYZ]W_&R=7EUM:1492-*VO$[,C5 M!HT0`A^'Z<+W4:&D`?T[`!7<(!],SZOCJ)RI=T.-<% MO3/;@J[7R=I3E#$OX829>/G!($?<"AQAS^I$/8MDZG5N4(,H&`Q&0OQ.3.)C MD_D'"V'IJEU;%5M;#)WA&JIDR:Q]'F7H7;H*BH6H\)>YM'_&X;%F"9>G+]:F MN:$1)]*D(DE%KE2.7^8*I@>DNQ%0]39TVQ"O$*TLT*,WKRIKI5[RLO&!-\'/]S=T-3X6O2)P) M_+PQC5%%\',=VQ+34BMV(V!A&@_ZM.Z(3L]4E);)DPUI&")!;;B@4C*I>2:/ MDDGDUQ#$#/$U\37Q=>'SQJ*IOV21IKS1PCUU+".?!XUW3%'EFM1@>OZP2(0PDGDJHUD:J6_D3LA8L3I86:)TV4 M%B*52>$S\37Q-?%UX?/&IH7HDKUF!#9TR5Y#+ME#=)HIB2UYQUZQ^DF7EVI\ MT5[C^M?I&JYG<@U7X\LX&MDV1-)-TKT.TOUZ[Z#Y&3FZ9(]2@@V0>$H)4NJ$ M4B?$U\37Q->%SZF=.3QB=3J1!G3:SPVA7B4)G=T^?'2+I) MNI=49M?>IS([*K.C?`"E!"EU0JD3XFOB:^+KA\QG/:*IH7.]'"RQ^J)K_&HD4TD.'C:K14?.<@Z&[4<#EZW! M3:GU,RU39J9U;U:;%EBGBL)%,$YC;0-)>@.29`VYFF(=]XVLH&ZH^I@5K M\C,32,./W[Z)^-:U:4Y^OK)&S(Y#R?Z?J?=91:^W#!L9CECT^7O-L[./VP\.$R+9*Y%8':&RU6ZU6MLYU M'WED%&A-OZ[LRB=F\BA@=L^#N48!(CN_-[G#967!F??9"QAP]W=F?S0=[W>? M\VDSJ;7P.*>MO8/Z80B2O=Z=]_JG)9.^ MNZVX!.DKW!=#;(RA[$SA)OIJ!RJ7C8#7@^!-\G+:OJ`'4]B4SMZ"=N7I]B0; M/'<50TJ1K,%S.$C8$$:'N(R+PCMV9PF59$P"QV+PEAD:MW[DVL:`X24-#`3+ M+K(<5NV9'@S!66C`ZXGIB$L<0M`Z<4#[AAX([YWB"#/C, MLYR)Z>)P8Y^'AFG?@!HRKYD?<6-L!O_"HY)JP>3!1;JRA\*P\%@_L%G@WDNZ M3"MT?`^F%=XRYL5#%JB9F$'H(!UX184O21MGK&G89LBTK'SJA4+O&Z")\ZP0 ML&^1$\A++B(.M*LUD2.'!9B&NS=N1XXU`J+NG#&PC-B;\B;B[_VAX0\X"V[0 MAX5YHAJ#N=K&V/&RW\9?S9,2>>5?WHYP+<04T:8,4^;),8YVSOT1"QA.&!X8 M,`:"=<-+-@^%L0!T$`P M1OQ)*W[38JX[,6TT=9I/^,2TRI\X=OP&RI"#_[/A.5MM7?35:NGB+[UJK0@U MIP1>\?E5+A(,_U"W MQ/?1BSQK&54U$SNZ=<_FEK8XTJ6OU$1H$?&[8'>$)\*%DV!AY!`[`UPX&`ZJ M<, M:@_U.$]D#\D>KFYQ:MA#'T+%(!>N83B718F;!G/$5VP(8:W0K;R5$>VFEWQI M,QX7!O0,(29&.[:YFP:/(,XUJ\G*FV@TR!S"6M<,]&9W,TT#E$B:,3<"#9321GL&]^M,X'V&;H8DD5@S`HP$F3T/'=#$)`5'Y,')=`\SN M&*/D-)/!E51&:1!R,>JY&!UR,93OD(OQ',S;5!>CHO^97`QR,5:V.#-<##2X MNJ1S:HUY-)GX06Q?P.9GN5,"=P=CX=! M)`Z9C-N1#PZ0R#B+K+UA,S3,XFPDXI@+1Q<$_ELE?V/?9B[X'[;#+3_R!B*$<-\3D$AV=>>\[0`=>G>/J1_/T3V=?BN`,>R8#1QF(\G??1 M#,_CJ4[[B@0^U8G?V;#(H\@,L:P5#UJ$&YI(2N)_@AQ5G:7AH=80'%APK,*1 MXP';BT'P=,V+SWR`[[@5.`,\51SX-VRSL+?X2`N\Z&L_<+Y+WG2X,3"1LOB0 M#60&."T>3E`NY=KA1;H4]A5'CB/U["AW6"==[/)695)5=:QEG/CCB>G=RS1I8H0"GB@^03!722[3I\R!9V*;"B7J/,OWN`/N M-&Z-%?KP7SYA%CZ[Q`F^P4P1<<5GM>D9:4&>IX46BSMI7USYP^-$3\I2_^OO M($Q."*;54LAZK(M<2];%LG1/3WJ7Q_VS'JQ6Y.%A-7Q6\/_`TS7NF MPV#L6`4DGDBF;))1WF.=[M:5-?)=F)<_$>P0.RS2,Q&4&!S("D#/JUY882C4 M)[&5AP=*1;6I\\QR/EA^PQ*'K%*AYNF]23E8DNHH;J1:8Z(@0VD1H(3?IN22 ME!^[8%'XS%*"FH4$@VO1`!IS&GAA(7M$`D/-4!SL+KXHP"AZ57/WM1K:8%"E MO]/2M'^7O4*]_GUX0?VEP__5/V6(%2@.YIO0C\"<'9]JTC+:9@:_NUMG'O,-=^%MO=TNWV0C?[ MN:B"J9S!0ZSDO?%=L#)HKQ\C0DU@C/;AKIXU2!.(O^1()7;41&D'WMRLLP'K MM.][VQ6%591567H@4&`XQ8-/U4J6QH@F<2)#NMGPSL@!)11@'1&6']OHI0_+ M$PPKD@V6/Q[#B$*/;1M]4:@MR5&/#ZL"%5[*KP1L;#J>B"7@YSPY?DR^+QY1 M9.<`G*TMX5>A.X4_"5@8!>7DS>?M*Q@@$#'+?5[(.':_X$H)CTPX]1!GX%N8 M5Q)I#!YB5D-$*Z$R3\U:*>>F*>$UDA@4[D[A\JO*;+#C6;BE,,YKF\4O?Y"% M]?=R&S"!'B>V'.0*(1>^5^)*2_03@&,>N:$80$WBN??@QPV'X+?###5I,4U6 M;-OXR#P,:^&WIA'W+\1!-\3DT5B&PR+S.?0U,7A>EH"=3->,ZQU@ M%/&0.$U?6*"J!_/TR=F#%)VAY%IULI:+8::Q]VRF&03&FRF*?_G9OFP*6`G/%8K2D<\+P_!"[);"VQA)-;HD" M]!APB&@AU*1T8L#M`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`CEKBX23U$)E-5C*:F&H5[=*.-;&VR)>(5XA7B%>(5XA7B&\",*+(+R( MQS!%8]0OM5T];-V>2]L5M7P_4LQ(>9#R>.BZD?(HKQPI#U(>I#Q>D/+H:#&P M27V0^B#UL<1U(_7QTM7'M*2;_(SP(LK\UA^QH-#'>@OO`.<8MS*QQ8T0_L.' M+.#&@(6WC'DJ?H2+1678<+,!!X%`O&,"';&-SG5TG4'1H=F##6<+YXK)#& M9/X/R[4;):W[\O+Y<17=9M5QEY&#QD%%UEYM%=-"W.,5'>@M\=BNBE>?NU,[ MTV&E7%GS3W])K:]:K7\`?Z5R,8P$#&V8>;T!LUR38U*<@YKE>0\`/;OA>GZCZ;C3='UOF=8(].[9AB)JE"8 MPZJ@N#P&6`<_P)0&#.$CL`6\L/PQ,UZSNPGS../:?KJ*S6F0I9B/Y9Y<,R^K M-:,1DZN?W*Z>W--;IM=[!\VW3,OHYEGFHM;HVJ5X91UMV,/34"MNIJ.XI.$& MHEG:?PT.-BDJH:B$HA*%,YMC)R@J61.CLWY127N?HA**2N:T=M06-W_\DB\& MJB.$ZV66J,CT19S'KV&1*5U*MHR`37XV1Y'I/Q$/G>']8HL59QN$QE8Q7D.@ M5!G*;!I#/Y!5IT8GC8@<>!PLHNL6=F7$7%&_F++5WL-EJ MM?`;A:%>M??QDTV@C$^8N/_%O9]9PIK-JZ*"\>V;B&]=F^;D9ZQ0^((AWR=9 M>#EF7BAA+[L.MUP?W^NSN_`] M5_T8`F[[*H1E[DU"Q_KH?=5?U**M8'5R+%$XL4+2J-0P8:HU'=TYP%E-5U227,:PTN'_ZM_RC!@ MF(P)&4A\:`1F6'53CL9$V!5F2#/?_=7.M[5]".PQPW6:-HFR#=1P1X,W_/0. MU3SV.Z6;K<7NMG/115,Y0R.]L"X\5TP!%5E@.O$ M&.W#73UKD"80?]C.DBL(!4?TGIF!S@:LT[[O;5<4""YFV_-14.:9+=;=.DJ? M^;;D/BL_0MO^`:SX66S$+\&&9U[G!!SJ>=S.GS:.0*NV#G\4-T/ M$[;LQK9H,51W)-6MZ43KGGWT`)J_I/IQ852WP6&I277^Z4?UR>ZCL->D[NAB M[VMGKUN/(ARX'*NEOU`N88RC/KOG72:W<;_'R[@?$V(TLRGNP8E\NCZ;[@*@ MNP`>9.7_B.CZ;+H^NZE+2]=G+W=]Z?KLI2\Q79]-UV?7=-@:>4,(>:+DB:ID MT5V2#5]'NCZ;KL]NP"K219QT?3:Y/.3RD,M#+L^RUY&NSR:KW9@EI.NSR6J3 MU7[&`D[79R]Q<44!?C6_&4;5;=JTOG4OT]:VT)$%:@2@)UVFW1!3.56UT$6F MQ"O$*\0KQ"O$*\0K#>&5.MY78S"RZ#)MNDR[IB017(AVNP@NI'%P(8V_XZ.A M8"&D/$AYS+UNI#S**T?*@Y0'*8\7I#P(J(S4!ZD/4A^D/AJ-<]ADL('E']82 MW`#53A7)?FGE)W]$!#=`<`--75J"&UCN^A+-7P="6Z`X`8:L(K4N$AP`^3RD,M#+@^Y/,M>1X(;(*O=F"4DN`&R MVF2UG[&`$]S`$AJ7^G1>9I\.]0@_4LQ( M>9#R>.BZD?(HKQPI#U(>I#Q>D/+H:$&327V0^B#UL<1U(_7QTM7'M*2;_"P! M&'C[)N);UZ8Y^?F#Z01?3#=B2C/<)V;R*&!VS[MD5A0$CG?]WN0.[[.[\#TF MJX[DR&^30;HL<&Y,[`=-A^L-LS>3H>^/QW[DA>=^V!L..0N/KTW'X^&)[[IF MR`+3-2+/"2_9\-U&Q.T-PP(6@$>*-ZS#OX]Y;]AI?S(#Q.7_.WV2K(L3E5V= M3Z)`8<.PF>6,39>_V]CJ;!S!FK9:V9071>U1LOXK78=6?AU6-M>53[2=S+3+ M+"R4>,B.=SK+V_'\2CQ$?M1:6#$'^-CW+/@5D.%[J7CEUP$F#BJS_:OIX7[W M_6SKCX2.:S).2(.3_H?ELHV2PGUYJ?RX@&ZSZJ3+,)(J,+Q&)7Q:O/W9^=Z:M2FJSY![^DUE>MUM%+J5P,`Y2>WC*]WCMHOF5:1B// M,A>U1L,NQ2OK:,,>GH9:<1\=Q24--Q#-TOYK<*9)40E%)125*)S9'#M!4_8E,ACO12$/30_+X::5&/Z4JS!LEVHI6^U<&>&T MQY2+03][`0,6^,YLC'U^]SGO>5G-(9]&U[Y:\K>#)7]Q#621PKV#'($S'KE0 M&JO+$HNKN/\X&J\B8(IO$?/"TQOX/SY?F>2JO(]_(AXZP_OJ!%^FVV`-XA_M M:'1`3KOUA78[!^UV.4.[S:$Z9PT>O_'GJ9SWP'<5_,'S7O^T.,6][4S77'U^ M?W7ZQV=89N/T"_S_55[Y5AJQG*\#KP?!F^3EU*WL[*U@+S6;N9K5?@KF>0SU MGA^`(L@>T/.*O/+)O(+6SNPG:QKAE`<-\$`.58H,6LV&4<,2,KL.M@(EA@GOCW`]A,J"_ MRP8Q8&,3TTB9@E=XVCCS4G(V,77U:^3"+)))P(/*`_(0&'$$F\D";MR.?&-D MWC!C;-I,$&8.?/BGAQ>^%:>7#H'J+G`&$7[GU6Y+3!1H9'=QYFSH!\;.YAXL MP>'AGL%'9@"S\X>%5?J/YX\=B\-HXS&0+NC:GB*4#Y703--7*NZRCK\(?(LQ MFZ,*OV18;6]?P-[?=]D@G-HCT"YH_78+&$KTAQ2>7NX3:&T<[>SF3-,T*C2E M_U>X=&><1\SN1NC$7(`9\VWA[8"$B$^FFM!V8K,B-[%9\`L``00E#@``!#D!``#M6VU3XCH4_GYG[G_H9;_< M':=;7E811YVIR+KXLK("ONS.SDYH`\1-TYJD!?SU-RD@%%K`0BW.7+^((*_/G[KT,)4J900APHC:ZK MZ&Y'R>TJ^<)!?O]@-Z\T&V4EG\T5A@^))S`B?UJ`0:5O8<*.,E-@_1;%GVS: MT?+9;$$;=\P,>Q[T94.@?Z_@]\Z52B7-__:E*T-A'<6P.>W^ZK)N=*$%5$08 M!\20``P=,+_QTC8`1S99P2XELH?\2QUW4V63FLNKA=RG/C,SQT/F%.60VAC> MP+;BFW[`!PX\RC!D.5A:Y+=U*6P?99Z);:F2PVQA.,8'V?);*,9LC$S)_0G` M\DWJ70AY1I$#-V^J@7>0CR##UT^3WVN1CVO'F[>O2@0NK'/QV8(DCHFS(T@K M-VYF&;#N%VSW8MCW\J@V$=@`V'"Q[T^7PHZ`A;#/(3&A.;91#AA3L#$3`A'; M1@`%2W>VZ1@$@Q;$1QF7J1T`G-\Z8Y"SLDNIK\DT62-#?+]N`];RG7OTG"9) MU"#F;-SBTZIF!I0.$.G<`NS" M)%YA-6!M2H,IU74:?$=`C;&-XN.R_-%4)'Q__'R;VM82);G] M:OYL:D)ZE,EEE!Y$G2Z7'\6[Q9*L1J$#D%GI.Y`PF*"7A0--S-Y*02+8&0F0 MGQ$@]KP9VI'TP&:U:P'4B:-ID;`8<)SW;*<@2\B*F`;Q M=(%4;!!E5>!MPM-"O*"#;:,P"]D:Z5+8U)RI<]OXT[6Q&)7)C3P?)*%(",I: MR9MM63;Q!TTN3YO%2#>\1NL4R,KFB-ETC!5I1AL*7S2393\,)N5XNIH"H?Q$ M[BGB;?5,$TE;`:Z)A*]*RL!!'.!$-GH14.D'T=74B*0J*HS&7-\\B&U'EA'K M''1@19;!'8H8/(5M9"`NMINNY?I+[:E+$>G,/I',*KBV5>\AY&V"_)$W?)YX M@QI_MS.U:NO$?)OU=2GF%B7*"TF)2!D6K6.C0Z.?=U>WGW_]O#<,YB\_Y?K-\63,??N#"+KEO79=/JX.S MQI-Q<>]UGY[HXTZK<++;P5<768HZVLG=6>MR0&K6OF[?5YYOOCX^[Y\X3]]^ ME%V[J+MW-SFSA"K5QFGE/%]R&M<7U:;I85@Y/6M87;13O"57^L.C]>SM>9_Y MN>?M>'<(.JUBL5CM5O8N"M^S%=[>Z^DW3[52KT*+I7.G:+#>CWQ%,Q\H[NBL M?]6]+9O%_7M9A_ ME'+]9G2V]LZT#^NU("4YU&:.1HZ3/C"9/3Z*&2RN'7F<*H+2<+Q+FR52)@B# MB;W#G[I6 M44HD^G;0P@1%BP9;XPTF2?(90$3R>TTF;=]@PG6%*-#T/6^IM.&EAD@6%ZV[ M,73S;XA`QA/TMUF(U$O2KY)DCJ#Y54]=(U69Q".=R+V(&V48`28AWHWHH2P%!F54TI'7FZ+K;$IA%R.4J.VAX0=)X,FDVG. M2[33Y;W.Q`XR7X$>OW(J1A?J)15RID9/?55[O9C!(O:$I\BX$R]W[(IP=@*$ M,?+.L)A2_HLDDBN&(Z5="%M/F"CZ-GW+2\0]"H$LH0Y_5\G,'9:$UHDEH%NQ M8JPAWPJT1AQ,;$[%F7LO;R;D+&ZZ9PL)Z#A'[/RIPEH[MO]+'HEHN7H-9'=C M*?B,\P2O[K[-C)S!?-_+XG)*1Q+N;>2$+_SN>TTXC6W.FI+(U937X*=\:R(. M5X%ZQ"L<(VJK&IF2';[\[Y7?ZS]02P,$%`````@`^7`00[B*S;\D%0``["X! M`!4`'`!Z;F]M+3(P,3,P,S,Q7V1E9BYX;6Q55`D``W5J#E)U:@Y2=7@+``$$ M)0X```0Y`0``[5WK<]HZ%O^^,_L_<+-?=N<.ESR:INFT.T.`]-(F@/HM'%\ M\O;XS=O3X\;#?:=Q?'ATXC]$GC"A]6.D8=!XF9D6?G\04?8R0N8?-IJTC@\/ M3UKA#P_\7[Y]H5_$?O]\XOWZZ/S\O.7]=?53#--^2,0>M;Y<7]WI4S#3FM#" MCF;I5`&&;['WY96M:PZT+0:[&IF_H/]JAC]KTJ^:1\?-DZ,_7K"Q,I'\QG!6 M:J("3EO^'P\\P!J-=\@VP2T8-[QW?.LLY^#]`8:SN4E-][Z;(C!^?_#3LF=- M"O;AB:_L'_2;;X1:;)O0H"1=:"9]Y;LI`,Y!@PI^N.W'7I8^`G6/Z!;]>ROS M\99B^[X--00L9PHZ0W(FY;<\5(,S@`9$'T>%X7M.9NH(71UCP)\N;.J69- M`(:6`1!<:-1??O;UFC$J6>=35G'RYM@+4]-_$+>72,$KK&:V`4Q^R-ED20,_ M["VD6\_\ID@8H)`3R@65XGG MU@6.!IE]>`'!Z>&HHH8`%)1WD]B8\G/\3E(KH[UL88.+@]P@[=%V8+CJ4^J0SKN"O%/Z/D MO2T+MD)=@.Z:D94(_5_OR84+S:2+IK;3(UL;RK`)Z#C1/*,XO=;A2S$%<0' MU1UE((%)@/PKZ4.9KT<=Z+O?UD,$`HA/)37NY&8'&>WN'%O_,;5-H@=W"1@Z M=+BF9G9I.PLZ+RH!*:^EM?NHOQ"U0\!%2GN\`N#%&EK2=TK%0MDR+]CWP4-M M25>>*H?^=$V5N$CB3!7AQN#IBO)$!!@1F]52E:%,Y7)<,5U9\!5ZMD)\E4-4 M)D,UI"B'FQPW5[`[=5UP;]\"DT;!AQJB2F]L2U?'5+Y"9=%AI8P5@,CB*0NR MMTKO*:>;Y>JK;8?+1['8"1'D`J M8`$YY_*[3-LP/%PT@YDUZ7IP,DGU'AS6UM5RV%4!AMA8Y$>WXB^ M"]V'HJ>/Y%.?HJ6V'3H-L9">O&VZ[=WVA*WJZ"K463-WDQW+D,C"R,>[5CP[ M,))P64K:8/+P[SZ+<)]%N,\BW&<1[K,(]UF$^RQ"1?$B,N<.D&>OX:VYAP#= M3" MRYRBM@CQ6%)5MS\8-*&.^*M!8!^>B"+3";5QI5"D>'8M4[FRZ*S-FQ1N^ M587=DA7L9`2N]M&V?;1M'VW;1]OVT;9]M&T?;8OR!$SR]<0O\VRV+:-MS`A* M=$^/9DP&Y_&44,:FN1:K&584E9T/'LQIE6YB@N\\7=E8R0R5IJ:*C"X^=E+! M88BPB22=#IPI0+Z>@'6NG-.8`=A:-44D4=5ND;L!3& MPK8\G?"!V$U[UTX"(YV'X/;+\'MM\#V^^![??`$EY6.,'B2V+S:J>@3>\T%:C3 MQBILEX,KG+"HJ@0V1/88.JH6\A'I%=;ZXFU\\0RO-3XLLXQ`WV@;WUWL^!>W MV;>`N!HZ-&F`FFJ]M\D'[P76MA/'E:N_;*6@9KQ)0+2XJXG-4T'H@:PV[!F- MU`7WY"B8HM(U57>\>9L.F`5;\<[R?KNM>O;8-^'R]JT%_`W_[L:^M;;7+R)O M&<+58?E$5E740WC0Y(6,X>B'Z+X/`AHM(^+_OV_%JY8KV@#*UUG/L;,82LG% ML;,5)RKS^&6!UY%-0?3[U\9$H_+-I(M3P7'7/IW=Z-+ M#$[YR:[Y=NPO)MJ6R:R+B>0N1N[<^=S?.-),>FDBSM5'D8S=WNPO1(#U M''E9F\,<-YL?"$[&FY+2&X34^S+2M(EZ$[FHW!/,+\CS/Y0$N-@T5YPX5DQP M+,[%B";;+EJ9_>3X@TU,[=B6#I`E1B$#=\!C&VT9+^$F]SP+T+ M1LYZVE(Y3&=H$E^_QP4J'96S5%4\#.>3%P]69V#%L/%7=LM_]9DXKMKZ?J_E M0>`CO?NMV6S\]_/UXZO__?>+/G=?OEJGY\;/L\7DZ])ZZ+K/'\[0^=FGX^\/ M]TMLGBWTGX?F1^?-0^=J:'S]RSPYM;Z,!IUN?_GA_DG_]&4Q?7I"WW\?G5R< M3LSK3X<(3EH7GS^,KI;6Z'^]D4_G[V:%VWOWZ?_5R\7KQR/BX6OR\^0S`? MG9V=]:>]UY]._G/8<\:OG]NW3\/SYQXZ._\X/]/Q\U_'O9;Q%9F3-GZYGCYV MC+,W7^A=BL?/@\?K1_<_G[3'Z8_[HX]('SJG)Z/VS=/_&IV[VV9S^[V@OD5: MC>MM*))%Q)_`F,26\V6-#>+F2-@/8U:J>)#9PIYJ\T$D-*?TK3419G9O+C^] MU"#REN'70*/6>B]T\&_Q67OSO95VSQQUXO-W&BA]:^XZ974X/@,J[F'%C$=[ M$">VS.D_9?::UW?N"(,GEYC>6VS989*B5/:63%WB^34)B6HC$)G**LXY+*`P M%G'(!FRW9H?->,C%TONTW**QUS[\=N%B:`&,NX`L@>'<:V260<_AX,%XB`"F MT5;ZK=*.(&!%M3V$+RHG`K*RPPB!VL0;!%U!+E3YRJN=%>5 MCS%&)`MW5[<,4>`2AL(<;17NP?+1E8>8NGN65X4J2F`I4U=]1L%LN!BJ=4L\ MH3`(O1YB$.G,I-$,3$,4-RIZ1R(B5TS2*5M:&R$#NEMSW/ M$9C28Z$T_$L'BM+6`LRZZ[3.8P=4666?R!)S,+X!SY$70+9%/NI^1/S&=KX" MIVW8Y43MDQVV.]ZIFY%K0Y(T;\$01]]:L$G M5\WZG=^(*IU;R;N;`@RHJ>9YIT^!X9ID9;M^P^AY.&=EJ=?UU.XZB-I2H4\E MN5V(T\%80:'Z+6\)0_BOL/.]9GJ]9AIJ2PI1^UE#_I4[_L()K\:#-L;NS/^N MS.XHQ<*J\^3X-L]ET\.88R<^E4=&B:"W&0/KEN:*(C(.>;L!Y212N&0/6;J$KLK-095-=LV'EB.8Y7YHP?+-46 MX6`(O50CO]2=9=5=8WXB-O-2.4HBH_%I5>3;0>A*Z`XPNI">?+:-,5E-UUY[5=$35W5"5 M9\.C;9(WH=&E*GA-:*^N-(!<8I.@*JIGE6?"/4"SLMGT=/XJ'/H`%I\9+[6L MM1\C@^2I,#[R[+^T&8L1\Y>ZCE>)6H=?DB%HL:I:#/*$*RRN.`Q$8^(SFAK& M7NU3OU0YD[$LK()Q-$ZIR*M<615*+-")^2?`-FW?6CEA]>V4OQ MB/5]*Z(\:3U'+V275EE]J"TZ(@=6A2Z#\J!):.R#A8!FTMOIPS*/58=)618WL*C>K+`HZ8ZS:ZP#=TIM",F]-D92.4J2SPEIBV[%=C"9SKF99SN>% MJ>D_[O0I^8Q7<:Z9;0!31K`K*GWEP5]3Z0)A+V9A^P"8L@["2^@^%%:O4)AL M?O=!L9T+BJFB>!\>^Y78W,5`6<2'G@4^M.:,R4M0QP70@E*A/SWRMJNW]3>`^?^LZ9.F$4<*'L M/'WJ2VZ:HN["/SX#*K\$D*_S%&9S9R.]&XRKN3^0FW/5A.?=*5@2XVP7#V[' MN._`>C8?7\XP9_*$$I$ M[4FY_)W\LOR=)/A3T8/4!+?<3`>8^"T)^0UL-.Q35-SR+N9*LB6 M9EMU`9=2%G+RN2P<+RK(JUZE-Z7@M$W&4W+++MQPC1PU$\FW9I*W3<\-$WG: MEN'M'&+%&[&Y^JJ\>4V`P&BOR<=1S:'3S4W[Z+69:JJ%%:BL*I=F2_8*D61Q M??8SY^[-G%NV"^ES8;'OM8-W%P5.1O0PE-KK84*%\BYCJ?**F+`QW=*WLH`1 M5@0B0+LSE[80HTO@U*&28]<,6JLX`\AWWPP/A*J."`^1/8:.JJS%B/0*4S&X M"8F"PCI'[NC5/Z*#SGJNJ/7U/^NZ&]&\*._6/F,($"TXITV49+!P:*\T.,-W M11`KGFQ%U/DI)GUH%2 MTZG85/]"5=B8T583!MN'4&K67DK<8:A@/,_=J!$>U'^%6FUKBFF4-1IA5=OU M-K156>B0K^91'F1,HVFEMXP)-OK5GF>6P(W]R\)LWF))@H>6\X3S)1SG2U&Y M-9:=/*)NI4TU2;"Y152;`RJ!)879K0J>ZO+IT115Z6X7C M2`XU/%FKHAM*.@`&OB0F1X*.2QKT4K3%E*VORM0;;D^##4%UZ:I>U>(^QBXP MNB[-JAL2M]PVO$7?#7CV_J+&K6!27&VBHA"3C(BR%FN5Q:A?0Z<*2I.::]D_ M65%EJ#13;ARG:^M>D*MM&3W+@Y2'7LVLRUOGO!G!:;T<[[Q)E='3:AA08NM<(8` M24-W9$+]TK2UG'4)'R=1D348EU)PD'\#+E74)A89U*I+4Y/0`>+B*ED7\$*= M0*#P%EMQB"/7^TE$.BJU#JY-.AP,=\F*COA$%:+W?AO@Y1/(*=7+.<@GQ%:3 MMR0XK"0A,@:40DQ=:I.VQ`4GRAJG!W\%1TB(\[L9&TL2@NM%8>9@*/<`4F=8GK M:_H,3/.393];=T##M@4,+QB4LRW!QT&6^%JQD8E1R(NT`NQ1^_P@G;15<;K8 M>@Q(&9"$\$NLI!#5MEZ`7Y)O)`8(DX)K,2]GHA*R('/!&U?FTZZ$A*CH.BP3 MFYO;2TR,#$S,#,S,5]L86(N>&UL550)``-U:@Y2=6H.4G5X"P`! M!"4.```$.0$``.T]^Y/;MM&_?S/?_X"FWW1\4UWNX3J.W30S\MW9N?@A]>YL MQ_5T.A0)24PH4B8IWF"V`_[%HW1U!([!1;1:W[H^N`Y3]%LW];<0_2SS"!/\`'!__"/#__O=_?L!(+F*(43P'=\L-&&\6 MX.P).'_\_/S[YT_.P?N["W!^>O:83D(S`C_\;>8D$#RL@C#YQS<,LH=9''P; MQ8N3\]/3QR?YP&_HR.5\?>/R>BS9\^>G9#?%D,3GS<0@3T[^>7MFUMW M"5?.L1\FJ1.Z&$'B/T_(#]]$KI/Z4:A`%Q".P/\ZSH<=XQ\=GYT?/S[[]B'Q MOOF1<@Z`'^(H@#=P#@CIS]/=&O[CF\1?K0-,$?G9,H9S/B5!')_@^2$!O@' M;Q!!%5+A0PI##WHYL1B$1-($`]&K`C`&';D5H`%6F2C.81+,__AFDQPO'&?] MG]L4T;>"83J9O_1#I&Z^$TRCQ,=*-IXE*?[^N+PCI,R=9$;HR<"=X$_I!`9I MDO_D&/_D^/0L4Z\_:^%%#,L7A:FN+"O_Y+5X1677F!'_"68!^8;1Y'"!Y!4> MO[_]YL=B*HCFH)@,\MG@\4Z/:XL[E^Y03<5K/8O[G]_OC M]VF3KRO_@B^<9#D./?S'U9>-OW4"A",9IQ=.'._\C>`E23NE3<`Q*S6+ZM[/@W MOC/S`^07P`0=-;=IY/ZVC`(/6<^7<.Z[?JIEVZM#,VOO*],ET`9F/G!"#[`0 M_N*LH^3O(`-DUV#5EF9AQ.IQR*`CH448S[E0EQW7[_BCRK"1<\+Z.RRV!OX_ M;[J5(`"'D)I(0%#.&$(X0"*(?1]5M%;S@0$!);+H`,OVH84(VLN@5;!@[+K1 M!OF&4V?GS((^'3D!)K/A`#X1@J\V'PS6=+1M:TXJJHIU)UYE4W\?@8PWT&-4 ML%]5$2"K:KH)=>$3(M88/)[=<-A-QI+6R`6WISB2]9[\V'"3,:,U0G4Q[!TJ M:TLU,,#7&1LJHZ8K$B5IIB67&W@7W<``7Z).G1@#?H>([4]AY`A/?C2XT4A) M$5U%0O1[M-FLD?#\)(GB'0BC%/DJ6)K`A7'J^"%(&&/>]EZD)&%6Q^K9LO>% MZRD)A')SZWY,NH]C_"KT1>'(^ M>G+V;/3]L^_RWR*C$SN[.#0>;5*]E7'!9U,:?&7L>2=-T@JGC>]?AA;/VD5G62X1.@,JT%R.@ M0Q2>*T8#G.YRC-QCETZP[1G7B*X2HY,LN47P!6YA$*UQXN]MZBS@%7Z/L8[] M!.9'L>MN5AOBB5]N8O2E[<_HQV-N355GYS`OR[\O7HK#R_F\W-"SFV#6G=94 MO?1.^-?BH&9-49Q`F>[ZT&X.%BL!ZT,ZI%Y^(O0ZK!^^8KE5GSAPU]M)[&G5XC6\(VM`DE*WG'A@(!'R$J\C(+`B1.P1OXK<4*.[+X+4!>WP)V5 M\J;Q/2^#@$!+QH6GUK/Z':`S_,I$3(F2MATXML,)CH@$*5`L[O([V-8HW&L2 M<3*B2QDJTPZM@`X=+:)A.>N'9(WPI/K#++JY578`=5*&B8RH$(O/NAXQQ.@H MTY!":RH"E:K5/@^:ZU8U?&?2YE+$;%K?U,A2BP(/V_C2$[TXYEMK@G6AF2;, ML!J,AAT`.36JUQ`R@VP`6J=BE"DPHK&ASX/=\^E:A]+PBV`9+9I*QCMBAZ)B M-2>L"B-:A&&O0S=:P:(B29\U:D2H3)^C`CH$*D5'@[(HS0`>MR@*CU4CV:*; MGX2W,$`_7M"Z8\$X],;>R@]]#!MG`&:/W7L)[*MA-JU;:F0)5"V;14*S3F5> M7NS`[E64GK0KUP'J;&FNC),U+GZ'T%!=?Q,EO:2)\M!TGOI1>P_`H4+T/!K] MBN:K1W1.%%K/4I>(BE4;T2*;9'"0_+=)NH0Q!9;IG%8NJ62ZV=>Q8D($2D`F M`)^>98^RW>3(8@YIO22*I,6:Q1I\'BNGA)<^*N#[0%)'.Q-"J_>QI"XI3-(> MK85]%%TZS.I)*WM4"`U..NKPS+=D8W*E4[4M#]?5V.\MWX^\2%D=WW137RYC\R MDG&GN2GY+@JCJNW1X^8D1M9#7*_6L!12(\TLB;CGG&75JI4BJU+R=3?>SDK+ M=9RFL3_;I+A!6C:$9C!>13#7,-2Y\'Z^S$D MOCL.O4L_V*3]7&76H31YR51#BT1G_,KA5%R;@[_\^?OSL[._`P*)!'(]"JON MFMV*KBF*G]4^%98U?>K]$?J+)0(RWB([;`&SW)+]&R^MB)TF2+-1/#WB1!4C M,B#`H5"`F^48'=Q\6HSV-9-L$7QJP"B#44%]ZGB10@TY#B1Z:%RHS:MB[N%Z MM\'/I"=[>U=-CH7:#J,*NO,;(R]R-SC&0RYXNN.!R.M?PD)10P()QY9R78W! M)O13X>OU=.FD`)^6FP3]EKP0#5S\U@S_Q[>CX1LC*DQ[B_M8?CDL5PX"(H"_L5^.6RJSA/XF5;*6.E MD,?$VS=:I'G]L9*\6G1*6B*&PN0Z+`UFVB0V9)LSZ#F]>B`-=U32(D[D_5(@ M.&C+^%$$#HGS\;LOF?>D&LFV]*?T666R29,V=5RW6$.2@C=O?WRQMLQK=V/H MX(IZ],_KL-H#MJ?<+#G.#O6T>LS=B38?5=*TV_U:LC54Q;J7Q%6_]J8E?`Z! M[S6G,J-H^TA[R?G25[(]LO3[D`U$R00RE6L9;_'-L\6X\/>:61G3M7V\QHPI M':J:]3`;CL8)A%NK=#PVM#A),[=_&D=;WX/>B]U[Y+^QQW@1Z>Y#_32P6R@( MJDZ=)+A-HDLD&V.VXUZ0V-X/]35@+V56AT>-:^DA',B6Q'_@@J/(+<=QK"ER M62-O_S/I0U&U\)M_LJY#GD17O6P(31Q">HN]%?(76$*UOITVT85*835=9O5A M;JT)NMO4B5-]P8[1-Q?'._1Y%:T7A->S3@IF<.&'.+481Z\H8KL%8%46I2XY M+C!R17QPDN_<0- MHF03:P85ZV"8C2+64".Z/V!F`:^<9K5#NZ)PRN99"DLW&`94((?;T$PDBB$4 MMNI++EWT;T?[P30*?%=X*=!1VQ\Q-I-/H\1DR",H^`#/9]B^GE87(*>SNVCE M;5J>^(O0G_NN$Z:'2.[@0_H"S?^MEQMG-;OJPA!O,!KB,,"H):1(H?0O:\IM5&DQ(CJIN`Y()LTF*-0 M23#%05B_;I-/26JIX>8UU(GA]RZ"9D\_Q+";?YV=FQ.U+]"X9(C*-'1*+>CX7/PR"'/P1%FG(B#\-%.@O1.'6Y)HM_"WV)B<+DR1/WA$M%X_L8[TC\&AV1*`CJ(F/!\#Y'+J(5D*-N^2O!,USC\#* M"9T%L;]SJB#.2*()8A&1(TB*,PRQCOP,<4O`'E+^--R!%?K5@@:BY^CKB6*, MSSLJ:<1`_!TRO94+?`EG M:>E:]^G^"C"9S8WE$R$XJ?!@4(ZV_SA?36C53$OA>IO>A55!]NK`LOR=_*-U)P)+?GSP4).L,VJY@2D>:6NEBJX@!2_35$6=&Y M&@8TM61?.GY,$@'>0@=#Q[I\':XWJ:E=5H\`&]NJ%H4";<0P``$R`@P80.&, M5'9.*UK:2#U8O=5G7O,GKIM9`K]L$((K$FKKM6J0")=12G-%8;5YH:<;*[F%/)>ZL:._K=?U5;#;"5.JD:;2(=S52VGCVC.SPY\ MSOXJOG+2?)U1[&,SE`_$)$*@5&H25JABF MJ%,V-(HO,E9S."MN8_H57LID_C*_'&=B.Y1!O7J_4L0&;Y2U"*MU=K'"%=/9 M".*@-S0M;>`ZN[5,:W[QF(<>$P-'K`2;\0?)8EIJ0]?#UK9ZD?)CSUPVM.Z5 M?N<\&%`L(2[S9Z>(%'FC)31>3:FL]E]2T"?I\EM%4[BER":Y1X+PXER_+9SB ME+7^#M@F9!C?VQH0*0K,8$A9*3L6U@A,2E^X@`<(P"%OCBVTJ+XN7CV#6VRG M^ZV$#.RJ=2B-ZW4-00(=SFNJ-V`76E<-*@_'=3C5HA5V$:&R8*%$+4<_%5DZ@NX3>)H"3>1FW8(N1I@5)=Z19 M=*\W[DUI,>\.-J14Y!-FX/`NS^1S,A!QR1OFT_A,P`[(F&FK1A57L`USVY1' M*/"6SNC4V>%O<'SOQ!XI0D\]TJ3X%,=)LEG1GYG\0#JAT$ZYA4[7H/!!L0&7 M#!$@F$:`X,KB+NB(*<\5!I_T6[/[J76IIOP/L#,1=6"!,5M`=CIZD_`&NILX M1B8@N:@VDP:K18B5;ZP1J0IYL>R!E,/#72`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`#BAJ2G*X MTOKM.`?-'8Q7IC61X!R._F%RZK0.G>`KIJ$IN8#$%1D3JY?JJH)5U;F"$[J: M5FUL6%[89*9Y[H?OFO4Q58!G-,"J2UU]%U.OO.X[:)G[W&[!OP92/6QUJ<@C M(X_RFU!6T[I4*C[KC_=-B_&T:0'P8FO*H"=G3G$[N>,<-Y8L&@VI[MDSJFPR MV$Q+BS#>"?1NLYK!&#NJA9DPE$/)D+A:%1C7N3C.J7H?QM`)_*_0>^7XX9LH MZ3?YNQUEMF+0K:B6WR4GY:XTE.!T)]K3-*&AAH^-S;<+;`T67]XDOO$7RW2R M27&+$-S"H@^MK\79_=ZLUKNTABY1WV"UW=G*,S1%Z5:>GZEPH6L;2$D^.C:E M)$-B.%N+*0.[<>CF1>"XO]VZ2[2>,AGX;>3!H$&JDS(PXTE/JI2)*H;AZ>^Y86]0I)N[4\2T3D`T7>1`\J^QRU^^),/8\2'Y>XR6B%/ MJU?O7XD`6TZ^"G'U]UO%!/"93AG.LP4=\=>^YY9RJ-DI^RY*X1,NLDN8.GZ0 M,)]/OHDX*=Y"R`X2A4ZQ?9#=@SP@43J#^\%LLD]P+RL0Q0$0+O`$'+-1=A8C M>)3A/$)C&N_\A`++1FFO&EF<"OW)KE$>5-?DO/%#>)W"E=KU5'_8S67G]+8& MJQ\DI@(0,NP:8[WK9V\?9E6.K3K)JL7$QJ03,EK&9#Y/8#I>H`,Z22^B('!2 MW)G;9JY"+6T6JE%W17O-\\&`$Y8==%Q658^:Q&V5>-GH(-N_9>6X7$V>L"K! M,Y_0JT&=JGH*S@>[-ED#J>X_M53FD3F309,RV;O8.O$-(Z'7H!B;W`KENUA^ ME38./7(_F/1\92S%U\>F(@N-R(B114(R*Y)Y;A(SV9@@C3@GH(WC3T6X[)%6 MRX\6W6,.TATF3+IZ/^UD:E!V%FM^1C4MA`MTHDLOOFM($N@<'HM]%I>F_Z%_ MS'E:R#.[K'2=41-UI0V-`E]Z2_WM*%E!Q<[CWF(ZZ)\N'%FOC?E[,99;W!3< M8+.WSLNIO5!L/V+N'<=_U>FIPJ8#5?0*F>*%%YB&PB*.K+/V+F@FSR MD>6,''5)LVJJR!0KY>*F<33WTSQ1D)M=#-.LH#IXA,<=C?`_@XU'"E%',2V: MF*:Q/]NDI/@4LE3>(5Y&88IH"/"PO!B&W2.D7"M/2ON<:&Z57,)96C:68@N! MW*98Z%,8XXX6SJ*7:@`:V*W$BE2I$Q9&GZ5,K[)1H5L``\%U/(;!K(YHU`.=-Z M?$^V+*ZN+((.7J7CR!`;%>KW;O<`F\5&K?NTU#9J'8$\9%C^;"`/ MT$52Y*L>=^5MFD=L9@G\LD&G[]46_><.3>DO*U2,S'`&J)`045^&8CP@$P"> MP4WWM--:H4Z(E2X)TK4WS^/\;@]PGC&CEY,IAV+J.DR-'%ENUG?@&.QK#9N5 MQ4EVM))6I22U2GI4/4NZUZ$WV@F%]9`,5DE0(JB5-KWA9NH-2J,.9*BD56\X M"73-3KII'+D0>LE+1"X3[]CA0%4?AYT4GZUXN9`B@?;E4P`6Y%R.0^:A\Y)>Z'K)-E`[W*#,T"GY#*5.`KOX#WY32_A!S7$%@+F2H2) M3"Y2-9=.!G0VH--'N4>*&XM2&)8[6^D(OF***?.G:0A6@($6<+"AE/N8[?1R M4Z*M@6)2"*QF#J9>AIXF*&@ICULM-L]#KV3\X/>CF0)4IG/M!'3HN:!XAMT^ MR362JW$]BQ5WT&>,OOY_`[

/P6XLHU?:B/#)VE$N&'E"@T[J*31H!,`X_! M9SIS,"WOQ-+DOE05\*#YP8E,0WQS?>O"T$'[76^[$1>1B5?_4@J$#4KID$%L M/#(150\PT0*[J+S'*-ZYV5WG?#"[SGG#7>=\R+O.N=ZN<][%KI,IZ/LP64.7 MY,[W&(T7(C,=C1<14K,)X9Z2Q8P!1>/KA%CM62Q;>^-+PCU+J[]]B8_(Z/'% MHT#5B#[8?@9@08NW'?%2NSC(7NP.*WR0G:TOTT<1LVF_3(TLA;..*0QCWUK2 M$S/WL*OG1[=.W)E9<^IL,.;464-SZFS(YM29GCEUUL*<(K=*EUGM^7'H786I MG^ZNPWD4KTBQ0*U'X$J`C)5I4Z%&E`Z3305.Z`$Z&3"S!U,84D=RQ26B,E\, MWON^BOQP<8%7&U?[!WD6T6L,P(=*? MD)9Q2"^N0_SBP-_"*6)\,HT"WQ465":@CF<8%F"!C0`%1[ZA`B`@$`$%"3YG M?_(:V5NQ+_79PK4^FW+7M`&G]_2$^\ZC\4.=/_Q+G>I;T]YE>9B:/79=G%^; M9`\)1"(4Y*[GLP^>4@PE:7UO>3R!*?*D@4_H0?\_]/1$G_@J"LG5'[WH4ZJ" MD4#WVT6T/4%PJ"V._K)O@BOB,+5IJ)$CZK9*C2@Z$Y"I^24P8&;;RO+3$R=6 M,0UN&-T&NLR]/^=N^!T_?_COXP>9`(SJ#J^<'W4T+_W$#2+\LXK=RCM.6%5@ MX!0.>`D*?!Z*W:>U<*E?KLXYL\&3NFP^GB254QK_".F,^U:`@;N<)?0V`=H< M2G88\&U?EA/+<,$"*H1/9`SARVA M:8,TTL$@S#+QNE_:S6H M,C^K$3)2<>`M*87J>GGBUN.5V1UKK^(HX??%&K:5UL8*8Z)O!M.( M%).9N1MZLVSO(672=ICNW:">%^.XH5T<&=K7H0\T'T7,:R]@P+H/Z$_06:.L:N^A7A&X-)YI1`@8HN4K)P((2 M;JU+;?\`U^>,_%!ORFG]M`N\Z8P1(@\C>QDX'<1TJ^#,V!X'>`6G0C$&X$&6 M[`]%[OWR#.\#B=K&",%97515G$1@P`Y M###;@4<8#/##(U!`8CYTVWN\^J)Y7Z\NRXR&/IGCY4)>V8X9.0(7PZAE=T@] M3P"B-1H.2"@4;.;QO9Q&*]30,J750C76OY!^ZE>;MVD.+TZG,5P[OG?U@/,9 M=.^2L\D@FVVY*I]\:6KWR#QV&-VP;OU%Z,]]UPG3[$X;N\DX3(4^[WJ'HYP- MRND@GR\R(ZTX%DH+Y;H1&BPRO`=>PL2-?1(CGLS?P7N&OC@*T5]=VDOK791^ M@NG8B]8I],3.0@$,.Y`X_,/*M`*07,ON\)TLA2F0M!UOH0%/^&Y"8^;:K:ZE M\-T>E+89S!VJ<"W<3U.^<+/QV+QB^Q3&Y)9'\6*DJ&&/YM&[-<5K$1O2J5DC M3T9*;+'VY(33+GH25EM$:Z4JL+&V'"`V+@N0X`73>W5(D;=&+)$F,>CSMF$& M79Z*/LV;J5PZJ:0XIVJ`A0_68!R>2T#=6P,Z&*#1``^W%H>7"B6/P(A7:#(. M_SZ!D_E5DOHKA%WL.28DL%Z,&_+M=75%7'^1LV:3/,1N]#H^, M1_JV,(C6I*@2?AEVA5^-K6,?'_:D*QS;)X[D.NW/$(?]BG&`#`0E[%'>2P]4 M^NO1=+&#B9;K^[=E$#\&V`W;[5^\($+C#?3VNJOH/>3#`(;=@>9PE6KW,"+N MF);;!6[A/)EG79`G,>F!O/<0C.L)X7EX?\X[E$GEIG#;U+<\&(QN>X`U\_59&Z!VWOA7*C&''`>]MK\36:LG4VQ3AH'R9S[JS._'T8KB!.P MV*/E+J('BV0;+)MF#_)0DJ]+L./5:Z4V_2PK/K.?:&:)\16B^9SF MK*M9DGH>M,*UXKL+.Q)H)@ZU?:1UL44\QOH5*!AL0A+51*92@3)Q1+Q M$";78?%&^0ZZR]#_(GEHR+PV8D&-0`8,&WOE._$2WN`*.4A7+\V#T&.A2=./ M>=3ZT@^=T/7Q:[CB38R\8ALCV6@.BOGL2Z/!QHB5%BX5:CW'3)?M0F?MG?.@ M&-#/[`TT8<#99J)%B8T-$0-,?E2*C=>EAL=!L32;AD<_C>?-%SZ8I5I/)V=I M_8M(6\4'E5\Z2M9LV"\J'FB5;H&(]^6CM8I;9'DWXBR`QW/A.LVVF%%M(:9; M'.*PXYKUH)R)3FO&/Q?VH7KHJ4>Z*X_]<=EI,MJZC.J64Q/,D["@1>6.CS`( M7H?1?7B++/0HA!Z1MZ3^O5X%#Q%X\Y4V!93(2WK@2<>_X5D@GT:_^-AB;'TSXU;P/HUD"XRUVOTCY4/1KQ`DT*XLX=?^@";<&*Y'2*JV@BK;F MS=/@'SVIB:]"N3`1U7OIN8BA9U0^'+9G"/KPA4"!Z+6>(M%$"KCP?C M&F=Z"3+6"IO)8\.5M()U]9/LHKE\@[WQ698MN?]SROA&!(EE] M;*NY3MO#5S&8K258P2WXAHM!63C0A7B'P4$#&VO=>Q8+B:D=UE<4!FBT#_?:W?"GH1^A?N'T2^3;_ M'U!+`P04````"`#Y`L``00E#@``!#D!``#M75MSVSBR?C]5 MYS]HO"]G:\J1+TD))(B M*0($"#%'\S**+'8WO@]H-!I-X-UOAX>M#P`!1W.!T1HO6_#R_USKGZW#UJ5M MS4O.W[;;CX^/+W3R4ZQ#!V#;M MP\,_6O2___V?=U3)I0.HBK>MNYG7ZGC3UO&KULGIVY,W;U^=M.[O+ELG1\>G MP4/D"1.BGV,-@]:392+\_B"F[&GLF"]L9]H^.3HZ;4<_/`A^^?:)?I'X_>.I M_^OC\_/SMO_7U4\QS/HA$7O<_OKI>J3/@*4=0H1=#>E4`89OL?_EM:UK+K11 M";M:N;^@_SJ,?G9(OSH\/CD\/7[QA(V#/P+D6JUWCFV"6S!I^::_=9=S\/X` M0VMN4HO\[V8.F+P_>$:V=4@Q/#H-9/R#?O.=,(9M$QH4^PO-I"T9S0!P#UI4 M\/UM/]$&^@C4??[:]._MW,?;?\BU[_M0B3[L0 MZPZ@SHK@T3$6_I``NN<`8^@06S"VG27])0N^+%*%-N?E%\UQ")?74!M#$[I+ M!J,WGR6FB3+LU94&G<^:Z8%/0,,$!SJ`62#-$2#0Q-Z&6DK8621`W=\XT-`48(@,X<*'1,/@QT&LFJ"P[GY85)VZ.O3`U_2>) M9HD4O,+*L@U@LD->3I8P\*/10H:U%71%$HA,2.^DN@&=?>BDXY#13X)HR-02 M+M&B._^*\PP3.$;"=G%*(KQ9DMW>8CF"C=X(Y-CMS14AQM2NK7L4@0XR>F2PN\L^ MFMB.Y4\T):TL%!&WF2+>!Z>+H&Q_[PZ/C,._T#R:]88#-WZAPBI-H_GK6JV8I MZ1V@3SYBJ=:NM<1Z::J?=IQD`S1'CVPB'SV0P+=]P?'+XZJ=Y>1#LBD!.W.$Y3+0T+1VFR5-"2&2B;@271$ MX!X*O$=X#G02A`&C:UL:1%*PSU76_F-'1D)6]TLPD8]7R,91P,8N-&9[?XJY MO-#\D]!\MNYT2591=#+&&+@X>\[*6WIG/KD;XW%C0J`8YC0UQGZ+V#P!Y%?& M=8!.KDV^02YP,/!_F9H1V$8R3=R38(C^K_?@0;(>I'%;Q[TDD?*2+%;\Z%/& MJ"ZG.-ZG=HY31@QC?I>1:S-&,Q?+0P?,-6CTGN8`81#V11FL9BO:X7&Y!:&8 M>^/GC(NRP%-(I"JI8'>BRD*:4JB$])QRN$_;UF"0.9,E*U)4>S'Q>0VT!3&?L0DQR/* MULV22V6.,E5K]:ITYF$G(C+DXK,>(G,9;!J%!=RI"QN['KBS;X%)MP.&FD.- MN[&1+H_.8H5J$D^5:-V"('\LNAJ=?,2N2C?J&::%^IHY8(LAY(]7S1-KFL9:EI8%R2B59(WGG=T4C',/Q=>??5N[D`,HN;HNF=Y?CS< M]6AM:OH).>%G9:N:YYQ%4!'U(Y:$T'G0CQ"84LG5YN%XD^F>)7U=1GSWR-#2 M3'^0!5=$(4<&*!GD5EV+I)HCC\ZM.IL4(Y<',B):6+KH73M=71J52==4=9I^ MYW5?A+HO0MT7H>Z+4/=%J/LBU/]W1:@9.1FBVU,,SE)JWP`^!U22:-U0UXRBUB*\%)8S M;-C5Q]BKB<-0U>X$/VP,1D@)*6H51=_`<^DI2@9$TUHXC.MK*I$)S/B+&:JS MFIV9'Q54AA)CS\J;X*50X#=P:AO0/^H=8%>B/TRKV)D9MG#0;`##D8_+J>SBY6K] M!L4',LW383Q`Z^]N@.0W4?*4*I_(V4%)EKP$2:[&9O"Y#;8*YQ@((_5.>PH[ MV06)@B=0(IN;JI1[5Q8>,Y`2DC?E]:S`E;LB2"IH"%4I5"J\-R;FI>F>YB#B MS7&T'7:A8:B3A687FIXK9P=JF\H=7DV41JW^-\N^`#B=$=V=!9F@IR#XB[N M+:X3#W[+UHTB<2C34*ND MH$EL5D.RPI9P:H#R3=)A&H,L+FR+)A'#"X`DS-#9FA2]OU-EV.9AINY\\_TF MI3AVR^]:"MB59HN$@CLM^VC=HN`&#&1PG_S,)E+)6H:'3%:H*FQC"@F3^DAW M@$8/O0G^WT?).Q0D;7X5ZVR@:]Z.(\?>9G+LWHFJ`4I;FCKNNA[*TTH;Z;)+ M8%GA$$U)`WSS..S:&$_K;8Q;9T-3U.&`!C`NEO>8OA*4T5)) MF^1EM3?0S;-@R[\E6^GXW,C4[/NLAB2@M(UT-Y;1$9CT[TAR,3/GQ0>HDHKK M8E/W]\%5ISOO/CB.M??<[SG$&,>M'M65LO;[D6+.?Q'6*8[\!S8$O/>0P<_Z MR)O/3;\QFDGOJ\XVPI\FXS=V#[,)&MK\P6NJNLMNJ#WKQ^//,O2G*4] M&<$I@A.H:\@-UQ6D!PYM$^HTP."_E'!#ELPZC`)MW!N\1;C<$=0OR/,_I>22 MRVE6[NRV4YS(*Y?$4]R>7NV#ZN2#3=IT:2,=.(CY0(3XPRL\F+QML03FM5ZF M.'Y#U#C[4JC2?IK3V@9WQU,Z;3G`/YW>67:,A7^J+]#)-&:0Q:4%,;:=)?TE MYCZ]HPO&[GIVE.GB5!YG1O/9XOIMR6Z[WJ/'\Z< M\[./)S_N[Y;8/%OHST?F7^Z;^\OKH?'M;_/T%?HZ'EQV^\L/=P_ZQZ^+V<.# M\^/W\>G%JZGYZ>.1`Z?MBR\?QM=+-+3>=.ROO>?;/W\\O[F8/]S\?>G99QWO MR^VQ<0Y[_;MN[Z^3\_G=X&/_WEB8H-?]<&?-X.]GG]&GSK*E^]=B M\?OB"P3S\=G967_6>_WQ]%]'/7?R^K%S^S`\?^PY9^=_S<]T_/CW2:]M?'/, M:0<_?9I]OC3.WGRE5Y.?/`X^WXR>'W[`L34W1IV[Q=7)4>]?VJ3SG];EZ/;P M4*+G>W6E0ZCM MG,<]$".ZHEQ.[2'%ZY$WQN#!(V)[BRIC*BU'ZFLL>;KXWPI)292;,,E5IGJ0 M;",QD2#)AZRAB]#-/,_%TO_$'66`6N)#E[!N!>:F6AB-&;G\HIUEYNH*Q$Y3$4W&1^CT& M@TD/N]#27#GE,BD-:NL@V#A,@R/P=+-JBX3895*Q)74XN\E<'!0J5ESTP,9M M22SY-\%%%+JM,R>X!D=B) MJCKGJS\D?=`!,](-_8T,ZIIJ6R*5UMVLA7)Y2"M4FHM9'L?6\H/)#7B,-=2Q M$?FH!YL8-[;[#;@=PYY+.NJ-SY"&+9XYT19WQICZ8@#_%)`JI3'[FH#,7<;5 MZZOT+V$63I\A^.#)27^P&Z$V1!>\]\_!@;!4*.?12C-@>"883-9(Q-]K=EHW*TE7EN4!GV">Q`_(>)2J_7/!]DE$E4GA5^A4F+='];KPZ&V]._6>M2< MX,*[8)&(5_ZE@[%G!=_5.6R%6*@\=F,LMA!-D.ISME8C,>9UPD%I#-`M+6EV MB%_S-WSJ*=%A,J1IW8<3;L'.7FHON4?V&`-G03NZ7X84'6T%Y>^^2[%3<<@J MKX.59TKTS4>U11OAPG,1>6+HU\4%AU"R!AJAK)57#VKLV$Y(+Q8A8H3&YII; MB']>.0!$5^[<:JZ4M\9+ZU:5P"O'7.8PV@IGW>`AEU M$IZIN]F$9\/)/Q?+(_RS;9)VTLR:"LI3VA552HCE/(VHNC,:BZR\`XY5-]N^ MSE^"XP`]_B(84U%*/5MG+=3XJG;SG.RBRA#R> M+:P5OZ%43&)84\/8/P8]N,JCE)UEY"@[7)B=$SH$2D&C*GQ9-R56J[:9`Y52 M65):=\,(9\>6/Y81P0,M?A9S?%VI;(5V8FOYSI,_( M9[S*_5JV`"XU-42]!.5RI$*+BULGQ26,Y98V=RGAW^9]+!HZO>)XB8E MBF6QOT\9[V+*6!;;34T>QY:"5K@4U-P):2B-DP`]SS!:%H[](A2N2"ECO1DK M91R@3G+MR10X\:Y6*X^_@F!0Z"9+:_!`IBR+E$NJ5E9P:!47Y(Y:6VA M0,!-S2OYP53J"S_^!*PQ<*12G*%.\?$,;/T^DZXL#)/W-POCZ*1>CDY^18Y. M4AR)'D>G]7)T^BMR=)KBZ$0$1W'7O6FCO)OJV0Q0_:ZT`"++`1U;@:EJL_2I M76(0GAP9LO=L.A9]TYDT9S"98.!VIH1"[%[:IJFYA%=3Y8[.5ML4N4;I*S"> M':+M1`I]T;7N]P56=709@'*7UJ5WZC)6@#PO$Y225V5-%Y6/=9#A;QECR=OO MA?J4K=\XV(L/K&(0!>P2<9Z0N%'M$;^T7,Z1B5M4*ME8K\CN5A@Y]H)R;G[? M3]"[-D%7[#O"IUSNNRR5EFPP7)T7QCT\<6#!U[`EU99<,Q MZ:J2"LRLQ1$1>%Y`_>Z)X7(]?N>UGGT;?^A"B>-F9?_VN,00./4-4FTJI M\V'0KCBGS'837UE$Q5X\HE">Y%(BBCC11?YAF?!+< M'Z?)/?!(R*%AT`7!_^.O6,02['(&7SG5JGVLT(,/2^.M]L#,?=ZL<3U+>#Z- M(QI8`&=L*]O$VKIC6&&J^!4.V5QW!IJMCV?JY0[3#6UJ3[)E.UBN"+1F[O5F MWBE:>80T\W+1(BS8JM:+I?"LC8JD7C.7DV^7I'@Z+'.Q:0FZ!!5TIY3*GA/:V[>("\+:2-3_EU;]S-B'63TD`O=91]-;,?RQ;.O4HND M,97NE!+$ZAH-`+\'TF[!%%(AR+W1K(*T#`;ZBZF]:),G@X%`/J3[?ZY4-0EU M%@IH+\\'I>(2CPJ.C*$!6764$]*4+!5XP$UBD(K;F!$-=QNO(-8U\QO0G!XR MNH5GK91%-U>R,H_-@W8^/GEO3%;FT5"&]<:G/"D6Q08A=8\X8CH3,BDAW-[)-`^>DC M*#@"G-%GI\2JRC95\-)I8&(W1_/'VN&,?`OFMD/?4:"UCE[!"I01]6SI#7(I MQ2C%KF7F\S"!^,^VZ1$(G.45-,EB4Q3Z:;'-Z_,;P$2KGB/>J3*0ZXN[)('G MU':$N9BDT`;&@2E4(JRK+#$#P5^`:7Y$]B,:`0W;"!A^4J9@YXH-^#SQ#:0@ M%ZF(#-XMA?A:=QB]\"=F:9HMMDG.)@>8"/-37F<3R5VO=Z_(-P+\>Y[@!DVL MN=A$J%=8<"9E!ZQ*03XNNCD1?`$\$?BOUD%E3K+[79O*'&L8^/_\+U!+`P04 M````"`#Y'-D550) M``-U:@Y2=6H.4G5X"P`!!"4.```$.0$``.U<6W,:.19^WZK]#UJ>,I4E;2`V MAHI=A3'Q$%_7X$LR-34EN@4HZ5:W)348__J5U!<:4%\@'B^U(4]8.CJW3SKG M2&KET[_*97"&"**0(PL,9@"WWW'G-U`&;=?Q>B8&7<)%K\GQ!(DV,D%4_"WZ MQYQ[3<.83JI18,$B.>69.98^1`\.S8A#6?!]3&1Z6$3-GRP:4C MH[JW5S,P81P2$Y5">N([>FJ+4X///&0("D2Q60(0^JW5ZM5(A'/;(%T6HNTJ1B/EQ<]I7VLCDL*:.22Y5RP@H;DQ\Z0RJ-1L-0O1'I"N4B!+)[`)F``-G(081_ M=JESBH;0M_E1Z)D/W.&H3K5*/9J3,+1H"9413.N"HQ+#CV7*6J+8Q1<.CDO1I.7+F M7S8&;&R9D8H(U9KV642:TW]PH(=/T;2U8BV9) MZKXP!,@?=[?=U,BDV(I&"%>`M@*S/XKE23*'``DY<^] M?RRBK$A!/3'%5*@1OUO@%$V0[7KJ;]$S0BJ%03(3O2%WH-@S\.Z.0-_"0NQO MGXQEWAK)/D/6-3E6OYNSA_ED?F"%[":6ET#)6Q@-7JBGL=%/^Z M@51X88PX%GJQ`J`NCRB`]2T0SBG%(@7J9ZC@;VMI: MT,:4#+A#<.W)C2L]W'$AG[K"'1T34U"8DO&6:KD\X)J,;@:(I2H$$MNN,TOE[`?-]@>0I M9J;M,I\B\8?D#E0V#B1("?Q_O@`*15![`+#`;8QGRVANMJO MC60+\!UJX9.I-&0&8FZ[.)D/T?YGB.D]M'UTB:#TJ*HPEG!*(S-2O9/C+(,H'J[(,EJ9(_+>\C0@XBOU[V)BR<]]AEYFU^G!@KU0D:539 MU4>E6CQ]@7!=*^T705Q?5?SQH MU^O=<>?@O/:?O0X?'DQ;MT\WC6F'UAM?O+K)IM^J' M2I9WGES1GV:EU)._5CK:'+G0=1-1SBG)F'A^6"(F@,NBRJDCUSC$FJ.6Z(UE M@D!H4X?H#L_X\FX,R0@Q3"Q$\03*;_&F@2?MA=U;\D*OZ)"\0E)_!)8/=:B` M`!C,50"A#B!68H?\AGM#?2#.ILV+QE7]*5KF_G!76A6$\L2&YH^>.1:_61S_ M'-="MCX\%Z//#M35E9.VXH#*3VJD"N50AT305EJ$H7N7B[-ACZ*CV$\[@9\M MR(?"^=*=2):LLDZE8KLR@`ROS(*-AN=,"OT97M%)D=`(1"H!R(%42LT1!,04 M@2!6#"C-=L5VD9(MSHL:L%/JM_PA.2F^NL&IH*:FB_5(F16[";#^Q9@^R:>2 MY>9W_:F@]I9LM]LJBMRI:_IR6;2(U2%<+(`N&;K445H$R&52Y'YRM5*41>R` MX`<"AB#!\=?!ZY.Q\`9$M09M"^]%@G;1C!W/I1P0[6.?M!=%P4.D"]=4_#*& MR+_*T;BR;"I7JN5:Y<,SL^+/Z==40QH>?-"_GAK1N(W4R'XXE**(4B(Y<@2A MIP8:R.8LYE6>\XHU6M,SJX^XBCAG>91T34.ZIG+P\XHDWVZMIXQ+KC+T*:"1 M]NE4T>D2#9#"]U?=$#[E4E*/2FU1S\DHQACBK#5@7+X++('@<8MZHM<4;:+B MZW+DR)5:`C"D.BIQZLMG*8K*$_:Z5E^-LWP:1DJ";5O6*Q$M$RE)Q#9?]IY1 MU_=*WR7 M[%?=.ON'T&9OXX"BBF>EBO`-"?M,72=\L"-<*)^1;UL0*JJIL5!*+IK;LK[[ MC`^8DM,M[VV)6M7G+S4\"LR)S@ M?V]H\JC]C8.S7K?T)!0< MY/5>O!@NY<7:MJW8PIIFK=U$_@QO$JP6G_N/M&ZCZR)9=FZ1]9LJGN6,W)OZ MS2X-W]A5%F^.Q4AJ^@/4773:WV/@6[KT`A-EU'*X^1_,P+_/M/3HM!S.-%-_ M>Y;H.LIFYJ"LR[6M7&/9RFYLZY9-_GPU,TXBLN[>MF<*%])2U?SJ?BLXW0^, M_B]02P$"'@,4````"`#YFYO;2TR,#$S,#,S,2YX;6Q55`4``W5J#E)U>`L``00E#@``!#D!``!0 M2P$"'@,4````"`#YFYO;2TR,#$S,#,S,5]C86PN>&UL550%``-U:@Y2=7@+``$$)0X```0